Delaware | 1-5759 | 65-0949535 | ||
(State or other jurisdiction of incorporation or organization) |
Commission File Number | (I.R.S. Employer Identification No.) |
þ Large accelerated filer | o Accelerated filer | o Non-accelerated filer (Do not check if a smaller reporting company) |
o Smaller reporting company |
Page | ||||||||
PART I. FINANCIAL INFORMATION |
||||||||
Item 1. Vector Group Ltd. Condensed Consolidated Financial Statements (Unaudited): |
||||||||
2 | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
38 | ||||||||
53 | ||||||||
53 | ||||||||
54 | ||||||||
54 | ||||||||
55 | ||||||||
56 | ||||||||
EX-31.1 | ||||||||
EX-31.2 | ||||||||
EX-32.1 | ||||||||
EX-32.2 | ||||||||
EX-99.1 | ||||||||
EX-101 INSTANCE DOCUMENT | ||||||||
EX-101 SCHEMA DOCUMENT | ||||||||
EX-101 CALCULATION LINKBASE DOCUMENT | ||||||||
EX-101 LABELS LINKBASE DOCUMENT | ||||||||
EX-101 PRESENTATION LINKBASE DOCUMENT | ||||||||
EX-101 DEFINITION LINKBASE DOCUMENT |
- 1 -
June 30, | December 31, | |||||||
2010 | 2009 | |||||||
ASSETS: |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 285,530 | $ | 209,454 | ||||
Investment securities available for sale |
70,732 | 51,743 | ||||||
Accounts receivable trade |
6,743 | 8,098 | ||||||
Inventories |
100,749 | 98,486 | ||||||
Deferred income taxes |
15,602 | 14,154 | ||||||
Restricted assets |
2,979 | 3,138 | ||||||
Other current assets |
3,480 | 4,135 | ||||||
Total current assets |
485,815 | 389,208 | ||||||
Property, plant and equipment, net |
46,341 | 42,986 | ||||||
Investment in Escena, net |
13,443 | 13,244 | ||||||
Long-term investments accounted for at cost |
45,971 | 50,323 | ||||||
Long-term investments accounted for under the equity method |
10,900 | | ||||||
Investments in non-consolidated real estate businesses |
56,111 | 49,566 | ||||||
Restricted assets |
5,713 | 4,835 | ||||||
Deferred income taxes |
37,662 | 39,838 | ||||||
Intangible asset |
107,511 | 107,511 | ||||||
Prepaid pension costs |
9,480 | 8,994 | ||||||
Other assets |
31,039 | 29,037 | ||||||
Total assets |
$ | 849,986 | $ | 735,542 | ||||
LIABILITIES AND STOCKHOLDERS DEFICIENCY: |
||||||||
Current liabilities: |
||||||||
Current portion of notes payable and long-term debt |
$ | 31,974 | $ | 21,889 | ||||
Current portion of employee benefits |
1,029 | 1,029 | ||||||
Accounts payable |
5,894 | 4,355 | ||||||
Accrued promotional expenses |
13,006 | 12,745 | ||||||
Income taxes payable, net |
15,387 | 19,924 | ||||||
Accrued excise and payroll taxes payable, net |
15,787 | 24,093 | ||||||
Settlement accruals |
60,525 | 18,803 | ||||||
Deferred income taxes |
23,965 | 17,254 | ||||||
Accrued interest |
16,959 | 13,840 | ||||||
Other current liabilities |
12,448 | 15,076 | ||||||
Total current liabilities |
196,974 | 149,008 | ||||||
Notes payable, long-term debt and other obligations, less current portion |
413,724 | 334,920 | ||||||
Fair value of derivatives embedded within convertible debt |
141,941 | 153,016 | ||||||
Non-current employee benefits |
35,135 | 34,247 | ||||||
Deferred income taxes |
49,261 | 45,120 | ||||||
Other liabilities |
32,549 | 23,913 | ||||||
Total liabilities |
869,584 | 740,224 | ||||||
Commitments and contingencies |
||||||||
Stockholders deficiency: |
||||||||
Preferred stock, par value $1.00 per share, 10,000,000 shares authorized |
| | ||||||
Common stock, par value $0.10 per share, 150,000,000 shares authorized,
74,605,075 and 74,510,595 shares issued and 71,357,164 and
and 71,262,684 shares outstanding |
7,135 | 7,126 | ||||||
Additional paid-in capital |
| 15,928 | ||||||
Accumulated deficit |
(9,299 | ) | | |||||
Accumulated other comprehensive loss |
(4,577 | ) | (14,879 | ) | ||||
Less: 3,247,911 shares of common stock in treasury, at cost |
(12,857 | ) | (12,857 | ) | ||||
Total stockholders deficiency |
(19,598 | ) | (4,682 | ) | ||||
Total liabilities and stockholders deficiency |
$ | 849,986 | $ | 735,542 | ||||
- 2 -
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Revenues* |
$ | 268,460 | $ | 206,794 | $ | 490,547 | $ | 328,010 | ||||||||
Expenses: |
||||||||||||||||
Cost of goods sold* |
210,994 | 147,764 | 380,905 | 220,290 | ||||||||||||
Operating, selling, administrative and general expenses |
22,028 | 20,183 | 43,186 | 41,713 | ||||||||||||
Litigation judgment expense |
14,361 | | 14,361 | | ||||||||||||
Gain on brand transaction |
| | | (5,000 | ) | |||||||||||
Restructuring charges |
| | | 1,000 | ||||||||||||
Operating income |
21,077 | 38,847 | 52,095 | 70,007 | ||||||||||||
Other income (expenses): |
||||||||||||||||
Interest expense |
(20,770 | ) | (17,086 | ) | (39,575 | ) | (33,160 | ) | ||||||||
Loss on extinguishment of debt |
| (18,444 | ) | | (18,444 | ) | ||||||||||
Change in fair value of derivatives embedded within
convertible debt |
13,789 | (19,488 | ) | 11,075 | (19,791 | ) | ||||||||||
Impairment charges on investments |
| | | (8,500 | ) | |||||||||||
Equity income from non-consolidated real
estate businesses |
7,207 | 1,811 | 11,778 | 816 | ||||||||||||
Gain on sale of investment securities available for sale |
6,447 | | 11,111 | | ||||||||||||
Other, net |
2,852 | 76 | 2,978 | 226 | ||||||||||||
Income (loss) before provision for income taxes |
30,602 | (14,284 | ) | 49,462 | (8,846 | ) | ||||||||||
Income tax expense (benefit) |
11,379 | (6,338 | ) | 18,301 | (4,000 | ) | ||||||||||
Net income (loss) |
$ | 19,223 | $ | (7,946 | ) | $ | 31,161 | $ | (4,846 | ) | ||||||
Per basic common share: |
||||||||||||||||
Net income (loss) applicable to common shares |
$ | 0.27 | $ | (0.11 | ) | $ | 0.43 | $ | (0.07 | ) | ||||||
Per diluted common share: |
||||||||||||||||
Net income (loss) applicable to common shares |
$ | 0.20 | $ | (0.11 | ) | $ | 0.41 | $ | (0.07 | ) | ||||||
Cash distributions and dividends declared per share |
$ | 0.40 | $ | 0.38 | $ | 0.80 | $ | 0.76 | ||||||||
* | Revenues and Cost of goods sold include excise taxes of $135,217, $103,458, $246,410 and $137,170, respectively. |
- 3 -
Accumulated | ||||||||||||||||||||||||||||
Additional | Other | |||||||||||||||||||||||||||
Common Stock | Paid-In | Accumulated | Comprehensive | Treasury | ||||||||||||||||||||||||
Shares | Amount | Capital | Deficit | Loss | Stock | Total | ||||||||||||||||||||||
Balance, December 31, 2009 |
71,262,684 | $ | 7,126 | $ | 15,928 | $ | | $ | (14,879 | ) | $ | (12,857 | ) | $ | (4,682 | ) | ||||||||||||
Net income |
| | | 31,161 | | | 31,161 | |||||||||||||||||||||
Pension-related minimum liability adjustments,
net of income taxes |
| | | | 972 | | 972 | |||||||||||||||||||||
Forward contract adjustments, net of income taxes |
| | | | 18 | | 18 | |||||||||||||||||||||
Unrealized loss on long-term investments
accounted for under the equity method, net of
income taxes |
| | | | (131 | ) | | (131 | ) | |||||||||||||||||||
Change in net unrealized gain on investment
securities, net of income taxes |
| | | | 16,043 | | 16,043 | |||||||||||||||||||||
Net unrealized gains reclassified into net income,
net of income taxes |
| | | | (6,600 | ) | | (6,600 | ) | |||||||||||||||||||
Unrealized gain on investment securities,
net of income taxes |
| | | | 9,443 | | 9,443 | |||||||||||||||||||||
Total other comprehensive income |
| | | | | | 10,302 | |||||||||||||||||||||
Total comprehensive income |
| | | | | | 41,463 | |||||||||||||||||||||
Tax benefit of options exercised |
| | 75 | | | | 75 | |||||||||||||||||||||
Distributions and dividends on common stock |
| | (17,882 | ) | (40,460 | ) | | | (58,342 | ) | ||||||||||||||||||
Restricted stock grants |
50,000 | 5 | (5 | ) | | | | | ||||||||||||||||||||
Exercise of stock options |
44,480 | 4 | 503 | | | | 507 | |||||||||||||||||||||
Amortization of deferred compensation |
| | 1,381 | | | | 1,381 | |||||||||||||||||||||
Balance, June 30, 2010 |
71,357,164 | $ | 7,135 | $ | | $ | (9,299 | ) | $ | (4,577 | ) | $ | (12,857 | ) | $ | (19,598 | ) | |||||||||||
- 4 -
Six Months | Six Months | |||||||
Ended | Ended | |||||||
June 30, 2010 | June 30, 2009 | |||||||
Net cash provided by operating activities |
$ | 55,852 | $ | 52,553 | ||||
Cash flows from investing activities: |
||||||||
Sale or maturity of investment securities |
15,433 | | ||||||
Purchase of investment securities |
(7,414 | ) | (10,667 | ) | ||||
Proceeds from sale or liquidation of long-term investments |
1,001 | 1,407 | ||||||
Purchase of long-term investments |
(5,000 | ) | | |||||
Investments in non-consolidated real estate businesses |
(924 | ) | | |||||
Distributions from non-consolidated real estate businesses |
3,539 | 2,364 | ||||||
Increase in cash surrender value of life insurance policies |
(529 | ) | (757 | ) | ||||
(Increase) decrease in non-current restricted assets |
(878 | ) | 446 | |||||
Issuance of notes receivable |
(535 | ) | | |||||
Proceeds from sale of fixed assets |
3 | | ||||||
Capital expenditures |
(9,244 | ) | (1,409 | ) | ||||
Net cash used in investing activities |
(4,548 | ) | (8,616 | ) | ||||
Cash flows from financing activities: |
||||||||
Proceeds from debt issuance |
79,585 | 38,246 | ||||||
Deferred financing costs |
(2,582 | ) | (216 | ) | ||||
Repayments of debt |
(2,429 | ) | (3,052 | ) | ||||
Borrowings under revolver |
472,865 | 306,788 | ||||||
Repayments on revolver |
(465,330 | ) | (306,167 | ) | ||||
Dividends and distributions on common stock |
(57,919 | ) | (58,310 | ) | ||||
Proceeds from exercise of Vector options and warrants |
507 | 182 | ||||||
Excess tax benefit of options exercised |
75 | 13 | ||||||
Net cash provided by (used in) financing activities |
24,772 | (22,516 | ) | |||||
Net increase in cash and cash equivalents |
76,076 | 21,421 | ||||||
Cash and cash equivalents, beginning of period |
209,454 | 211,105 | ||||||
Cash and cash equivalents, end of period |
$ | 285,530 | $ | 232,526 | ||||
- 5 -
1. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
(a) | Basis of Presentation: |
The condensed consolidated financial statements of Vector Group Ltd. (the Company or Vector) include the accounts of VGR Holding LLC (VGR Holding), Liggett Group LLC (Liggett), Vector Tobacco Inc. (Vector Tobacco), Liggett Vector Brands Inc. (Liggett Vector Brands), New Valley LLC (New Valley) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated. |
Liggett is engaged in the manufacture and sale of cigarettes in the United States. Vector Tobacco is engaged in research related to reduced risk cigarette products and the sale of cigarettes in the United States. New Valley is engaged in the real estate business and is seeking to acquire additional operating companies and real estate properties. |
The interim condensed consolidated financial statements of the Company are unaudited and, in the opinion of management, reflect all adjustments necessary (which are normal and recurring) to state fairly the Companys consolidated financial position, results of operations and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission. The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year. |
Certain reclassifications have been made to the 2009 financial information to conform to the 2010 presentation. |
(b) | Distributions and Dividends on Common Stock: |
The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders equity to the extent of retained earnings and accumulated paid-in capital. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital. Any amounts then exceeding accumulated paid-in capital are recorded as an increase to accumulated deficit. |
(c) | Earnings Per Share (EPS): |
Information concerning the Companys common stock has been adjusted to give retroactive effect to the 5% stock dividend paid to Company stockholders on September 29, 2009. All per share amounts have been presented as if the stock dividends had occurred on January 1, 2009. |
Net income for purposes of determining basic EPS was as follows: |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Net income (loss) |
$ | 19,223 | $ | (7,946 | ) | $ | 31,161 | $ | (4,846 | ) | ||||||
(Income) loss attributable to
participating securities |
(405 | ) | 364 | (671 | ) | 222 | ||||||||||
Net income (loss) available to
common stockholders |
$ | 18,818 | $ | (7,582 | ) | $ | 30,490 | $ | (4,624 | ) | ||||||
6
Net income for purposes of determining diluted EPS was as follows: |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Net income (loss) |
$ | 19,223 | $ | (7,946 | ) | $ | 31,161 | $ | (4,846 | ) | ||||||
Income attributable
to 3.875% Variable Interest Senior
Convertible Debentures |
(3,509 | ) | | | | |||||||||||
Expense attributable
to 6.75% Variable Interest Senior
Convertible Exchange Notes |
| 1,046 | ||||||||||||||
(Income) loss attributable to
participating securities |
(331 | ) | 364 | (694 | ) | 222 | ||||||||||
Net income
(loss) available to
common stockholders |
$ | 15,383 | $ | (7,582 | ) | $ | 31,513 | $ | (4,624 | ) | ||||||
Basic and diluted EPS were calculated using the following shares: |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Weighted-average shares for
basic EPS |
70,755,098 | 69,103,606 | 70,738,872 | 69,098,358 | ||||||||||||
Plus incremental shares
related to stock options and
non-vested restricted stock |
249,318 | | 202,261 | | ||||||||||||
Plus incremental shares related
to convertible debt |
6,218,867 | | 6,617,278 | | ||||||||||||
Weighted-average shares for
fully diluted EPS |
77,223,283 | 69,103,606 | 77,558,411 | 69,098,358 | ||||||||||||
The following stock options, non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three and six months ended June 30, 2010 and 2009 but were not included in the computation of diluted EPS because the effects are considered anti-dilutive. |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Number of stock options |
609,442 | 5,535,475 | 609,442 | 5,535,475 | ||||||||||||
Weighted-average exercise price |
$ | 17.86 | $ | 11.04 | $ | 17.86 | $ | 11.04 | ||||||||
Weighted-average shares of
non-vested restricted stock |
10,326 | 691,064 | 5,220 | 450,095 | ||||||||||||
Weighted-average expense per share |
$ | 16.82 | $ | 13.50 | $ | 16.82 | $ | 14.12 | ||||||||
Weighted-average number of shares
issuable upon conversion of debt |
10,107,972 | 15,099,336 | 9,709,561 | 14,343,459 | ||||||||||||
Weighted-average conversion price |
$ | 15.59 | $ | 16.11 | $ | 16.48 | $ | 15.84 | ||||||||
7
(d) | Comprehensive Income: |
Other comprehensive income is a component of stockholders equity and includes such items as the unrealized gains and losses on investment securities available for sale, forward foreign contracts and minimum pension liability adjustments. The Companys comprehensive income was $21,818 and $41,463 for the three and six months ended June 30, 2010, respectively. The Companys comprehensive loss was $3,882 and $5,095 for the three and six months ended June 30, 2009, respectively. |
(e) | Fair Value of Derivatives Embedded within Convertible Debt: |
The range of estimated fair market values of the Companys embedded derivatives was between $144,966 and $139,031. The Company recorded the fair market value of its embedded derivatives at the midpoint of the inputs at $141,941 as of June 30, 2010. The estimated fair market value of the Companys embedded derivatives could change significantly based on future market conditions. (See Note 4.) |
(f) | New Accounting Pronouncements: |
In June 2009, the FASB issued an amendment to the accounting and disclosure requirements for transfers of financial assets. The guidance requires additional disclosures for transfers of financial assets and changes the requirements for derecognizing financial assets. The Company adopted this guidance for interim and annual reporting periods beginning on January 1, 2010. The adoption of this guidance did not impact the Companys condensed consolidated financial statements. |
In June 2009, the FASB issued an amendment to the accounting and disclosure requirements for the consolidation of variable interest entities. The amended guidance eliminates exceptions to consolidating qualifying special purpose entities, contains new criteria for determining the primary beneficiary, and increases the frequency of required reassessments to determine whether a company is the primary beneficiary of a variable interest entity. This guidance also contains a new requirement that any term, transaction, or arrangement that does not have a substantive effect on an entitys status as a variable interest entity, a companys power over a variable interest entity, or a companys obligation to absorb losses or its right to receive benefits of an entity must be disregarded. The elimination of the qualifying special-purpose entity concept and its consolidation exception means more entities will be subject to consolidation assessments and reassessments. The Company adopted this guidance for interim and annual reporting periods beginning on January 1, 2010. The adoption of this guidance did not impact the Companys condensed consolidated financial statements. |
In January 2010, the FASB issued authoritative guidance intended to improve disclosure about fair value measurements. The guidance requires entities to disclose significant transfers in and out of fair value hierarchy levels and the reasons for the transfers and to present information about purchases, sales, issuances, and settlements separately in the reconciliation of fair value measurements using significant unobservable inputs (Level 3). Additionally, the guidance clarifies that a reporting entity should provide fair value measurements for each class of assets and liabilities and disclose the inputs and valuation techniques used for fair value measurements using significant other observable inputs (Level 2) and significant unobservable inputs (Level 3). This guidance is effective for interim and annual periods beginning after December 15, 2009 except for the disclosure about purchases, sales, issuances and settlements in the Level 3 reconciliation, which will be effective for interim and annual periods beginning after December 15, 2010. The Company adopted this authoritative guidance, with the exception of the disclosures about purchases, sales, issuances and settlements in the Level 3 reconciliation. The adoption of this guidance did not impact the Companys 2010 condensed consolidated financial statements. The remaining disclosures will be added to the Companys future filings when applicable. |
8
2. | INVENTORIES |
Inventories consist of: |
June 30, | December 31, | |||||||
2010 | 2009 | |||||||
Leaf tobacco |
$ | 44,153 | $ | 48,942 | ||||
Other raw materials |
3,148 | 3,497 | ||||||
Work-in-process |
2,063 | 2,388 | ||||||
Finished goods |
68,532 | 59,294 | ||||||
Inventories at current cost |
117,896 | 114,121 | ||||||
LIFO adjustments |
(17,147 | ) | (15,635 | ) | ||||
$ | 100,749 | $ | 98,486 | |||||
The Company has a leaf inventory management program whereby, among other things, it is committed to purchase certain quantities of leaf tobacco. The purchase commitments are for quantities not in excess of anticipated requirements and are at prices, including carrying costs, established at the commitment date. At June 30, 2010, Liggett had leaf tobacco purchase commitments of approximately $38,100. |
All of the Companys inventories at June 30, 2010 and December 31, 2009 have been reported under the LIFO method. |
3. | LONG-TERM INVESTMENTS |
Long-term investments accounted at cost consist of the following: |
June 30, 2010 | December 31, 2009 | |||||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||||
Value | Value | Value | Value | |||||||||||||
Investment partnerships |
$ | 45,134 | $ | 61,013 | $ | 49,486 | $ | 68,679 | ||||||||
Real estate partnership |
837 | 1,063 | 837 | 1,261 | ||||||||||||
$ | 45,971 | $ | 62,076 | $ | 50,323 | $ | 69,940 | |||||||||
The fair value determination disclosed above would be classified as Level 3 under the fair value hierarchy disclosed in Note 8 if such assets were recorded on the condensed consolidated balance sheet at fair value. The fair values were determined on unobservable inputs and were based on company assumptions, and information obtained from the partnerships based on the indicated market values of the underlying assets or investment portfolio. |
The changes in the fair value of the long-term investments accounted for at cost as of June 30, 2010 and 2009 were as follows: |
2010 | 2009 | |||||||
Balance as of January 1 |
$ | 69,940 | $ | 54,997 | ||||
Unrealized
gain (loss) on long-term investments |
1,018 | (357 | ) | |||||
Balance as of March 31 |
70,958 | 54,640 | ||||||
Revision for partnership now
accounted for under the equity
method |
(5,790 | ) | | |||||
Distributions |
(1,002 | ) | | |||||
Unrealized
(loss) gain from long-term investments |
(2,090 | ) | 8,432 | |||||
Balance as of June 30 |
$ | 62,076 | $ | 63,072 | ||||
9
Long-term investments accounted for under the equity method: |
The Company recorded equity income of $2,770 related to a limited partnership for the three and six months ended June 30, 2010. Included in this amount is the impact of an error identified by the Company, which resulted in an out-of-period adjustment of approximately $1,650 (approximately $980 after taxes). The error occurred because the Companys ownership in the limited partnership increased from a nominal percentage to more than 10% during the fourth quarter of 2008 (due to significant withdrawals from other partners); thus, commencing in the fourth quarter of 2008, the Company should have retroactivity accounted for under the equity method for all previous periods in which the investment was held. The Company assessed the materiality of this error on all previously issued financial statements in accordance with the SECs Staff Accounting Bulletin (SAB) No. 99 and concluded that the error was immaterial to all previously issued financial statements. The impact of correcting this error in the current year is not expected to be material to the Companys 2010 consolidated financial statements. This adjustment was recognized within other income in the consolidated statements of operations. The carrying value of this investment was approximately $10,900 as of June 30, 2010 which approximated its fair value because the underlying securities are classified as available for sale. |
4. | NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS |
Notes payable, long-term debt and other obligations consist of: |
June 30, | December 31, | |||||||
2010 | 2009 | |||||||
Vector: |
||||||||
11% Senior Secured Notes due 2015, net of unamortized
discount of $3,733 and $4,849 |
$ | 321,267 | $ | 245,151 | ||||
6.75% Variable Interest Senior Convertible Note due
2014, net of unamortized discount of $39,173 and $39,755* |
10,827 | 10,245 | ||||||
6.75% Variable Interest Senior Convertible Exchange Notes
due 2014, net of unamortized discount of $67,517 and
$69,749* |
40,013 | 37,781 | ||||||
3.875% Variable Interest Senior Convertible Debentures due
2026, net of unamortized discount of $83,321 and $83,589* |
26,679 | 26,411 | ||||||
Liggett: |
||||||||
Revolving credit facility |
24,917 | 17,382 | ||||||
Term loan under credit facility |
6,489 | 6,755 | ||||||
Equipment loans |
7,955 | 4,852 | ||||||
V.T. Aviation: |
||||||||
Note payable |
3,166 | 3,882 | ||||||
VGR Aviation: |
||||||||
Note payable |
3,500 | 3,687 | ||||||
Other |
885 | 663 | ||||||
Total notes payable, long-term debt and other obligations |
445,698 | 356,809 | ||||||
Less: |
||||||||
Current maturities |
(31,974 | ) | (21,889 | ) | ||||
Amount due after one year |
$ | 413,724 | $ | 334,920 | ||||
10
* | The fair value of the derivatives embedded within the 6.75% Variable Interest Convertible Note ($21,053 at June 30, 2010 and $23,890 at December 31, 2009, respectively), the 6.75% Variable Interest Senior Convertible Exchange Notes ($39,699 at June 30, 2010 and $47,552 at December 31, 2009, respectively), and the 3.875% Variable Interest Senior Convertible Debentures ($81,189 at June 30, 2010 and $81,574 at December 31, 2009, respectively) is separately classified as a derivative liability in the condensed consolidated balance sheets. |
Revolving Credit Facility Liggett: |
Liggett has a $50,000 credit facility with Wachovia Bank, N.A. (Wachovia) under which $24,917 was outstanding at June 30, 2010. Availability as determined under the facility was approximately $12,100 based on eligible collateral at June 30, 2010. |
11% Senior Secured Notes due 2015 Vector: |
In September 2009, the Company sold an additional $85,000 principal amount of its 11% Senior Secured Notes due 2015 (the Senior Secured Notes) at 94% of face value in a private offering to qualified institutional investors in accordance with Rule 144A of the Securities Act of 1933. |
In April 2010, the Company sold another $75,000 principal amount of the Senior Secured Notes at 101% of face value in a private offering to qualified institutional investors in accordance with Rule 144A of the Securities Act of 1933. The Company will amortize the deferred costs and debt premium related to the additional Senior Secured Notes over the estimated life of the debt. The Company received net proceeds from the 2010 offering of approximately $73,500. |
In June 2010, the Company completed an offer to exchange the Senior Secured Notes issued in September 2009 and April 2010 for an equal amount of newly issued 11% Senior Secured Notes due 2015. The new Senior Secured Notes have substantially the same terms as the original notes, except that the new Senior Secured Notes have been registered under the Securities Act. |
Non-cash Interest Expense Vector: |
Components of non-cash interest expense is as follows: |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Amortization of debt discount |
$ | 1,810 | $ | 2,896 | $ | 3,448 | $ | 5,577 | ||||||||
Amortization of deferred finance costs |
1,140 | 998 | 2,142 | 1,952 | ||||||||||||
$ | 2,950 | $ | 3,894 | $ | 5,590 | $ | 7,529 | |||||||||
Fair Value of Notes Payable and Long-term Debt: |
June 30, 2010 | December 31, 2009 | |||||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||||
Value | Value | Value | Value | |||||||||||||
Notes payable and
long-term debt |
$ | 445,698 | $ | 692,763 | $ | 356,809 | $ | 573,439 |
11
5. | CONTINGENCIES |
Tobacco-Related Litigation: |
Overview |
Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. New cases continue to be commenced against Liggett and other cigarette manufacturers. The cases generally fall into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (Individual Actions); (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging the use of the terms lights and/or ultra lights constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (Class Actions); and (iii) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (Health Care Cost Recovery Actions). As new cases are commenced, the costs associated with defending these cases and the risks relating to the inherent unpredictability of litigation continue to increase. The future financial impact of the risks and expenses of litigation and the effects of the tobacco litigation settlements discussed below are not quantifiable at this time. For the six months ended June 30, 2010 and 2009, Liggett incurred legal expenses and other litigation costs totaling approximately $17,626 and $2,960, respectively. |
Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related or other litigation are or can be significant. |
Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that 43 states now limit the dollar amount of bonds or require no bond at all. Liggett has secured approximately $2,478 in bonds as of June 30, 2010. |
In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny lawsuits in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. The legislation applies to judgments entered after the effective date and remains in effect until December 31, 2012. Certain plaintiffs have challenged the constitutionality of the bond cap statute. Although the Company cannot predict the outcome of such challenges, it is possible that the Companys financial position, results of operations, or cash flows could be materially affected by an unfavorable outcome of such challenges. |
The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided |
12
any amounts in the consolidated financial statements for unfavorable outcomes, if any. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be vigorously defended. However, Liggett may enter into settlement discussions in particular cases if it believes it is in the best interest of the Company to do so. |
Individual Actions |
As of June 30, 2010, there were 35 individual cases pending against Liggett and/or the Company, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. In addition, there were approximately 7,014 Engle progeny cases (defined below) pending against Liggett and the Company, in state and federal courts in Florida, and approximately 100 individual cases pending in West Virginia state court as part of a consolidated action. The following table lists the number of individual cases by state that are pending against Liggett or its affiliates as of June 30, 2010 (excluding Engle progeny cases in Florida and the consolidated cases in West Virginia): |
Number | ||||
State | of Cases | |||
Florida |
15 | |||
New York |
9 | |||
Louisiana |
5 | |||
West Virginia |
2 | |||
Maryland |
2 | |||
Missouri |
1 | |||
Ohio |
1 |
Liggett Only Cases. There are currently five cases pending where Liggett is the only tobacco company defendant. Cases where Liggett is the only defendant could increase substantially as a result of the Engle progeny cases. In February 2009, in Ferlanti v. Liggett Group, a Florida state court jury awarded compensatory damages of $1,200 as well as $96 in expenses, but found that the plaintiff was 40% at fault. Therefore, plaintiffs award was reduced to $720 in compensatory damages. Punitive damages were not awarded. Liggett appealed the award. In May 2009, the court granted plaintiffs motion for an award of attorneys fees but the amount has not yet been determined. In Hausrath v. Philip Morris, a case pending in New York state court, where two individuals are suing, plaintiffs dismissed all defendants other than Liggett. There has been no recent activity in the case. The other three individual actions, in which Liggett is the only tobacco company defendant, are dormant. In Davis v. Liggett Group, another Liggett only case, judgment was entered against Liggett in the amount of $540 plus attorneys fees. The judgment was paid by Liggett and this matter is concluded. |
The plaintiffs allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity and violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (RICO), state RICO statutes and antitrust statutes. In many of these cases, in addition to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars. |
13
Defenses raised in individual cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, equitable defenses such as unclean hands and lack of benefit, failure to state a claim and federal preemption. |
In addition to awards against Liggett, including Davis and Ferlanti (and the Engle progeny cases described below), jury awards in individual cases have also been returned against other cigarette manufacturers in recent years. The awards in these individual actions, often in excess of millions of dollars, may be for both compensatory and punitive damages. There are several significant jury awards against other cigarette manufacturers which are currently on appeal and several awards which are final and have been paid. |
Engle Progeny Cases. In 2000, a jury in Engle v. R.J. Reynolds Tobacco Co. rendered a $145,000,000 punitive damages verdict in favor of a Florida Class against certain cigarette manufacturers, including Liggett. Pursuant to the Florida Supreme Courts July 2006 ruling in Engle, which decertified the class on a prospective basis, and affirmed the appellate courts reversal of the punitive damages award, former class members had one year from January 11, 2007 in which to file individual lawsuits. In addition, some individuals who filed suit prior to January 11, 2007, and who claim they meet the conditions in Engle, are attempting to avail themselves of the Engle ruling. Lawsuits by individuals requesting the benefit of the Engle ruling, whether filed before or after the January 11, 2007 deadline, are referred to as the Engle progeny cases. Liggett and the Company have been named in approximately 7,014 Engle progeny cases in both federal (3,862 cases) and state (3,152 cases) courts in Florida. Other cigarette manufacturers have also been named as defendants in these cases, although as a case proceeds, one or more defendants may ultimately be dismissed from the action. These cases include approximately 8,284 plaintiffs, approximately 3,862 of whom have claims pending in federal court and 5,082 in state court. Duplicate cases were filed in federal and state court on behalf of approximately 660 plaintiffs. The number of Engle progeny cases will likely increase as the courts may require multi-plaintiff cases to be severed into individual cases. The total number of plaintiffs may also increase as a result of attempts by existing plaintiffs to add additional parties. |
As of July 31, 2010, in addition to the Lukacs case described below, the following Engle progeny cases have resulted in judgments against Liggett: |
Compensatory | Punitive Damages | |||||||||||
Date of Verdict | Case Name | County | Damages Against Liggett | Against Liggett | ||||||||
August 2009 |
Campbell v. R.J. Reynolds | Escambia | $ | 156 | None | |||||||
March 2010 |
Douglas v. R.J. Reynolds | Hillsborough | $ | 1,350 | None | |||||||
April 2010 |
Clay v. R.J. Reynolds | Escambia | $ | 349 | $ | 1,000 | ||||||
April 2010 |
Putney v. R.J. Reynolds | Broward | $ | 3,017 | None |
These judgments are all currently on appeal or will be appealed. As of June 30, 2010, there were 43 Engle progeny cases scheduled for trial in 2010 and 2011, where Liggett and the Company are named defendants. For further information on the Engle case and on Engle progeny cases, including a description of the Lukacs case, see Class Actions Engle Case, below. |
Class Actions |
As of June 30, 2010, there were seven actions pending for which either a class had been certified or plaintiffs were seeking class certification, where Liggett is a named defendant, including one alleged price fixing case. Other cigarette manufacturers are also named in these actions. Many of these actions purport to constitute statewide class actions and were filed after May 1996 when the United States Court of Appeals for the Fifth Circuit, in Castano v. American Tobacco Co., reversed a federal district courts certification of a purported nationwide class action on behalf of persons who were allegedly addicted to tobacco products. |
14
Plaintiffs allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. |
Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption. |
Engle Case. In May 1994, Engle was filed against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking. In July 1999, after the conclusion of Phase I of the trial, the jury returned a verdict against Liggett and other cigarette manufacturers on certain issues determined by the trial court to be common to the causes of action of the plaintiff class. The jury made several findings adverse to the defendants including that defendants conduct rose to a level that would permit a potential award or entitlement to punitive damages. Phase II of the trial was a causation and damages trial for three of the class plaintiffs and a punitive damages trial on a class-wide basis, before the same jury that returned the verdict in Phase I. In April 2000, the jury awarded compensatory damages of $12,704 to the three class plaintiffs, to be reduced in proportion to the respective plaintiffs fault. In July 2000, the jury awarded approximately $145,000,000 in punitive damages, including $790,000 against Liggett. |
In May 2003, Floridas Third District Court of Appeal reversed the trial court and remanded the case with instructions to decertify the class. The judgment in favor of one of the three class plaintiffs, in the amount of $5,831, was overturned as time barred and the court found that Liggett was not liable to the other two class plaintiffs. |
In July 2006, the Florida Supreme Court affirmed the decision vacating the punitive damages award and held that the class should be decertified prospectively, but determined that the following Phase I findings are entitled to res judicata effect in Engle progeny cases: (i) that smoking causes lung cancer, among other diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants placed cigarettes on the market that were defective and unreasonably dangerous; (iv) that defendants concealed material information knowing that the information was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vi) that defendants sold or supplied cigarettes that were defective; and (vii) that defendants were negligent. The Florida Supreme Court decision also allowed former class members to proceed to trial on individual liability issues (using the above findings) and compensatory and punitive damage issues, provided they filed their individual lawsuits by January 2008. In December 2006, the Florida Supreme Court added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations made by defendants. In October 2007, the United States Supreme Court denied defendants petition for writ of certiorari. As a result of the Engle decision, approximately 8,495 former Engle class members have claims pending against the Company and Liggett and other cigarette manufacturers. |
Three federal district courts (in the Merlob, Brown and Burr cases) ruled that the findings in Phase I of the Engle proceedings cannot be used to satisfy elements of plaintiffs claims, and two of those rulings (Brown and Burr) were certified by the trial court for interlocutory review. The certification was granted by the United States Court of Appeals for the Eleventh Circuit and the appeals were consolidated (in February 2009, the appeal in Burr was dismissed for lack of prosecution). In July 2010, the Eleventh Circuit ruled that plaintiffs do not have an unlimited right to use the findings from the original Engle trial to meet their burden of establishing the elements of their claims at trial. Rather, plaintiffs may only use the findings to establish specific facts that they demonstrate with a |
15
reasonable degree of certainty were actually decided by the original Engle jury. The Eleventh Circuit remanded the case to the district court to determine what specific factual findings the Engle jury actually made. |
Lukacs Case. In June 2002, the jury in a Florida state court action entitled Lukacs v. R.J. Reynolds Tobacco Co., awarded $37,500 in compensatory damages, jointly and severally, in a case involving Liggett and two other cigarette manufacturers, which amount was subsequently reduced by the court. The jury found Liggett 50% responsible for the damages incurred by the plaintiff. The Lukacs case was the first case to be tried as an individual Engle progeny case, but was tried almost five years prior to the Florida Supreme Courts final decision in Engle. In November 2008, the court entered final judgment in the amount of $24,835 (for which Liggett was 50% responsible), plus interest from June 2002 which, as of June 30, 2010, was in excess of $15,000 (for which Liggett was 50% responsible). Plaintiff filed a motion seeking an award of attorneys fees from Liggett based on plaintiffs prior proposal for settlement. In March 2010, the Third District Court of Appeal affirmed the decision, per curiam. The defendants motion for reconsideration was subsequently denied in May 2010. In June 2010, Liggett paid its share of the judgment and settled claims for attorneys fees and accrued interest for a total payment of approximately $14,361. This matter is concluded. |
Other Class Actions. In Smith v. Philip Morris, a Kansas state court case filed in February 2000, plaintiffs allege that cigarette manufacturers conspired to fix cigarette prices in violation of antitrust laws. Plaintiffs seek to recover an unspecified amount in actual and punitive damages. Class certification was granted in November 2001. Discovery is ongoing. |
Class action suits have been filed in a number of states against cigarette manufacturers, alleging, among other things, that use of the terms light and ultra light constitutes unfair and deceptive trade practices, among other things. One such suit, Schwab [McLaughlin] v. Philip Morris, pending in federal court in New York since 2004, sought to create a nationwide class of light cigarette smokers. In September 2006, the United States District Court for the Eastern District of New York certified the class. In April 2008, the United States Court of Appeals for the Second Circuit decertified the class. The case was voluntarily dismissed with prejudice by the plaintiffs in July 2010. In December 2008, the United States Supreme Court, in Altria Group v. Good, ruled that the Federal Cigarette Labeling and Advertising Act did not preempt the state law claims asserted by the plaintiffs and that they could proceed with their claims under the Maine Unfair Trade Practices Act. This ruling has resulted in the filing of additional lights class action cases in other states against other cigarette manufacturers. Although Liggett was not a defendant in the Good case, an adverse ruling or commencement of additional lights related class actions could have a material adverse effect on the Company. |
In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, are alleged to have been exposed to secondhand smoke from cigarettes which were manufactured by the defendants, and who suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. In October 2004, the trial court stayed this case pending the outcome of the appeal in Scott v. American Tobacco Co. (see discussion below). |
In June 1998, in Cleary v. Philip Morris, a putative class action was brought in Illinois state court on behalf of persons who were allegedly injured by: (i) defendants purported conspiracy to conceal material facts regarding the addictive nature of nicotine; (ii) defendants alleged acts of targeting their advertising and marketing to minors; and (iii) defendants claimed breach of the publics right to defendants compliance with laws prohibiting the distribution of cigarettes to minors. Plaintiffs sought disgorgement of all profits unjustly received through defendants sale of cigarettes to plaintiffs and the class. In March 2009, plaintiffs filed a third amended complaint |
16
adding, among other things, allegations regarding defendants sale of light cigarettes. The case was then removed to federal court on the basis of this new claim. In November 2009, plaintiffs filed a revised motion for class certification as to the three proposed classes, which motion was denied by the court. In February 2010, the court granted summary judgment in favor of defendants as to all claims, other than a lights claim involving another cigarette manufacturer. The court granted leave to the plaintiffs to reinstate the motion as to the addiction claims. Plaintiffs filed a Fourth Amended Complaint in an attempt to resurrect their addiction claims. In June 2010, the court granted defendants motion to dismiss the Fourth Amended Complaint. In July 2010, the court denied plaintiffs motion for reconsideration. |
In April 2001, in Brown v. Philip Morris USA, a California state court granted in part plaintiffs motion for class certification and certified a class comprised of adult residents of California who smoked at least one of defendants cigarettes during the applicable time period and who were exposed to defendants marketing and advertising activities in California. In March 2005, the court granted defendants motion to decertify the class based on a recent change in California law. In June 2009, the California Supreme Court reversed and remanded the case to the trial court for further proceedings regarding whether the class representatives have, or can, demonstrate standing. In August 2009, the California Supreme Court denied defendants rehearing petition and issued its mandate. In September 2009, plaintiffs sought reconsideration of the courts September 2004 order finding that plaintiffs allegations regarding lights cigarettes are preempted by federal law, in light of the recent United States Supreme Court decision in Altria Group v. Good. In March 2010, the trial court granted reconsideration of its September 2004 order granting partial summary judgment to defendants with respect to plaintiffs lights claims on the basis of judicial decisions issued since its order was issued, including the United States Supreme Courts ruling in Altria v Good, thereby reinstating plaintiffs lights claims. Since the trial courts prior ruling decertifying the class was reversed on appeal by the California Supreme Court, the parties and the court are treating all claims currently being asserted by the plaintiffs as certified, subject, however, to defendants challenge to the class representatives standing to assert their claims. In June 2010, plaintiffs filed a motion seeking collateral estoppel effect from the findings in the case brought by the Department of Justice (see DOJ Lawsuit described below). Trial is scheduled to start May 6, 2011. |
Although not technically a class action, in In Re: Tobacco Litigation (Personal Injury Cases), a West Virginia state court consolidated approximately 750 individual smoker actions that were pending prior to 2001 for trial of certain common issues. In January 2002, the court severed Liggett from the trial of the consolidated action, which commenced in June 2010 and ended in a mistrial. If the case were to proceed against Liggett, it is estimated that Liggett could be a defendant in approximately 100 of the individual cases. |
In July 2010, an action entitled Calistro v. Altria Group was commenced against Liggett and other cigarette manufacturers, in the U.S. Virgin Islands, on behalf of a putative class of smokers who contend they were injured by the defendants alleged fraudulent concealment and other purported misconduct regarding the addictive nature of nicotine and the promotion of light cigarettes. The plaintiffs seek equitable relief, compensatory and punitive damages, including, without limitation, damages for medical monitoring and nicotine rehabilitation programs. |
In addition to the cases described above, numerous class actions remain certified against other cigarette manufacturers, including Scott. In that case, in May 2004 a Louisiana jury awarded plaintiffs approximately $590,000 against other cigarette manufacturers to fund a statewide 10-year smoking cessation program for members of the class. In April 2010, the Louisiana Fourth Circuit Court of Appeal affirmed in part prior decisions ordering the defendants to fund a statewide 10-year smoking cessation program. The court of appeal reduced the amount of the judgment to approximately $241,000, plus interest from July 2008. |
Health Care Cost Recovery Actions |
As of June 30, 2010, there were three active Health Care Cost Recovery Actions pending against Liggett. Other cigarette manufacturers are also named in these cases. The claims asserted in health care cost recovery actions vary. Although, typically, no specific damage amounts are pled, it is possible that requested damages might be in |
17
the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was unjustly enriched by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees. |
Other claims asserted include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. |
DOJ Lawsuit. In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover an unspecified amount of health care costs paid and to be paid by the federal government for lung cancer, heart disease, emphysema and other smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants, to restrain defendants and co-conspirators from engaging in alleged fraud and other allegedly unlawful conduct in the future, and to compel defendants to disgorge the proceeds of their unlawful conduct. Claims were asserted under RICO. |
In August 2006, the trial court entered a Final Judgment and Remedial Order against each of the cigarette manufacturing defendants, except Liggett. In May 2009, the United States Court of Appeals for the District of Columbia affirmed most of the district courts decision. In February 2010, the government and all defendants, other than Liggett, filed petitions for writ of certiorari to the United States Supreme Court. In the governments petition, it sought reinstatement of its claims for remedies, including disgorgement of industry profits. In June 2010, the United States Supreme Court, without comment, denied review of the appeals. It is unclear what impact, if any, the Final Judgment will have on the cigarette industry as a whole. To the extent that the Final Judgment leads to a decline in industry-wide shipments of cigarettes in the United States or otherwise results in restrictions that adversely affect the industry, Liggetts sales volume, operating income and cash flows could be materially adversely affected. |
In City of St. Louis v. American Tobacco Company, a case pending in Missouri state court since December 1998, the City of St. Louis and approximately 38 hospitals and former hospitals seek recovery of costs expended by the hospitals on behalf of patients who suffer, or have suffered, from illnesses allegedly resulting from the use of cigarettes. In June 2005, the court granted defendants motion for summary judgment as to claims for damages which accrued prior to November 16, 1993. In April 2010, the court further determined that each plaintiff is barred from seeking damages which accrued more than five years prior to the time that that plaintiff joined the suit. In that same order, the court granted partial summary judgment for defendants barring plaintiffs claims for future damages. In July 2010, the court dismissed certain other claims brought by plaintiffs, on the grounds they were preempted. Defendants have filed other summary judgment motions that remain pending. Trial is scheduled to start on January 10, 2011. |
In June 2005, the Jerusalem District Court in Israel added Liggett as a defendant in an action commenced in 1998 by the largest private insurer in that country, General Health Services, against the major United States cigarette manufacturers. The plaintiff seeks to recover the past and future value of the total expenditures for health care services provided to residents of Israel resulting from tobacco related diseases, court ordered interest for past expenditures from the date of filing the statement of claim, increased and/or punitive and/or exemplary damages and costs. The court ruled that, although Liggett had not sold product in Israel since at least 1978, it might still have liability for cigarettes sold prior to that time. Motions filed by defendants are pending before the Israel Supreme Court seeking appeal from a lower courts decision granting leave to plaintiff for foreign service of process. |
18
In May 2008, in National Committee to Preserve Social Security and Medicare v. Philip Morris USA, a case pending in the United States District Court for the Eastern District of New York, plaintiffs commenced an action to recover damages equal to twice the amount paid by Medicare for the smoking-related health care services provided from May 21, 2002 to the present, for which treatment defendants allegedly were required to make payment under the Medicare Secondary Payer provisions of the Social Security Act. In July 2008, defendants filed a motion to dismiss plaintiffs claims and plaintiffs filed a motion for partial summary judgment. In March 2009, the court granted defendants motion and dismissed the case. In May 2009, plaintiffs noticed an appeal to the United States Court of Appeals for the Second Circuit. Oral Argument is scheduled in September 2010. |
Upcoming Trials |
In addition to the January 2011 trial in the City of St. Louis case and the May 2011 trial in the Brown case, both discussed above, as of June 30, 2010, there were 43 Engle progeny cases that are scheduled for trial in 2010 and 2011. The Company and/or Liggett and other cigarette manufacturers are currently named as defendants in each of these cases, although as a case proceeds, one or more defendants may ultimately be dismissed from the action. Cases against other cigarette manufacturers are also currently scheduled for trial in 2010 and 2011. Trial dates are subject to change. |
MSA and Other State Settlement Agreements |
In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors. |
In November 1998, Philip Morris, Brown & Williamson, R.J. Reynolds and Lorillard (the Original Participating Manufacturers or OPMs) and Liggett (together with any other tobacco product manufacturer that becomes a signatory, the Subsequent Participating Manufacturers or SPMs) (the OPMs and SPMs are hereinafter referred to jointly as the Participating Manufacturers) entered into the Master Settlement Agreement (the MSA) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the Settling States) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State. |
As a result of the MSA, the Settling States released Liggett from: |
| all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and |
| all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business. |
The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of Participating Manufacturers. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each Participating Manufacturer to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits Participating Manufacturers from licensing third parties to |
19
advertise tobacco brand names in any manner prohibited under the MSA; and prohibits Participating Manufacturers from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities. |
The MSA also requires Participating Manufacturers to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of Participating Manufacturers. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA. |
Under the payment provisions of the MSA, the Participating Manufacturers are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each Participating Manufacturer and are not the responsibility of any parent or affiliate of a Participating Manufacturer. |
Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. According to data from Management Science Associates, Inc., domestic shipments by Liggett and Vector Tobacco accounted for approximately 2.7% of the total cigarettes sold in the United States in 2009. For the six month period ending June 30, 2010, Liggett and Vector Tobaccos domestic shipments accounted for approximately 3.3% of the total cigarettes sold in the United States. If Liggetts or Vector Tobaccos market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. Liggett and Vector Tobacco paid $54,435 for their 2009 MSA obligations. |
Certain MSA Disputes |
NPM Adjustment. In March 2006, an economic consulting firm selected pursuant to the MSA determined that the MSA was a significant factor contributing to the loss of market share of Participating Manufacturers, to non-participating manufacturers, for 2003. This is known as the NPM Adjustment. The economic consulting firm subsequently rendered the same decision with respect to 2004 and 2005. In March 2009, a different economic consulting firm made the same determination for 2006. As a result, the manufacturers are entitled to potential NPM Adjustments to their 2003, 2004, 2005 and 2006 MSA payments. The Participating Manufacturers are also entitled to potential NPM Adjustments to their 2007, 2008 and 2009 payments pursuant to an agreement entered into in June 2009 between the OPMs and the Settling States under which the OPMs agreed to make certain payments for the benefit of the Settling States, in exchange for which the Settling States stipulated that the MSA was a significant factor contributing to the loss of market share of Participating Manufacturers in 2007, 2008 and 2009. A Settling State that has diligently enforced its qualifying escrow statute in the year in question may be able to avoid application of the NPM Adjustment to the payments made by the manufacturers for the benefit of that Settling State. |
For 2003 through 2009, Liggett and Vector Tobacco disputed that they owe the Settling States the NPM Adjustments as calculated by the Independent Auditor. As permitted by the MSA, Liggett and Vector Tobacco withheld payment associated with these NPM Adjustment amounts. The total amount withheld or paid into a disputed payment account by Liggett and Vector Tobacco for 2003 through 2009 is $29,236. In 2003, Liggett and Vector Tobacco paid the NPM adjustment amount of $9,345 to the Settling States although both companies continue to dispute this amount. At June 30, 2010, included in Other assets on the Companys condensed consolidated balance sheet was a noncurrent receivable of $6,542 relating to such payment. |
20
The following amounts have not been expensed by the Company as they relate to Liggett and Vector Tobaccos NPM Adjustment claims for 2003 through 2005: $6,542 for 2003, $3,789 for 2004 and $800 for 2005. Liggett and Vector Tobacco have expensed all disputed amounts related to the NPM Adjustment since 2005. |
Since April 2006, notwithstanding provisions in the MSA requiring arbitration, litigation was filed in 49 Settling States over the issue of whether the application of the NPM Adjustment for 2003 is to be determined through litigation or arbitration. These actions relate to the potential NPM Adjustment for 2003, which the independent auditor under the MSA previously determined to be as much as $1,200,000 for all Participating Manufacturers. All but one of the 48 courts that have decided the issue have ruled that the 2003 NPM Adjustment dispute is arbitrable. All 47 of those decisions are final and non-appealable. One court, the Montana Supreme Court, ruled that Montanas claim of diligent enforcement must be litigated. This decision has been appealed. In response to a proposal from the OPMs and many of the SPMs, 45 of the Settling States, representing approximately 90% of the allocable share of the Settling States, entered into an agreement providing for a nationwide arbitration of the dispute with respect to the NPM Adjustment for 2003. The agreement provides for selection of the arbitration panel beginning November 1, 2009 and that the parties and the arbitrators will thereafter establish the schedule and procedures for the arbitration. In June 2010, the three person arbitration panel was selected and procedural hearings have commenced. Because states representing more than 80% of the allocable share signed the agreement, signing states will receive a 20% reduction of any potential 2003 NPM adjustment. There can be no assurance that Liggett or Vector Tobacco will receive any adjustment as a result of these proceedings. |
Gross v. Net Calculations. In October 2004, the independent auditor notified Liggett and all other Participating Manufacturers that their payment obligations under the MSA, dating from the agreements execution in late 1998, had been recalculated using net unit amounts, rather than gross unit amounts (which had been used since 1999). |
Liggett objected to this retroactive change and disputed the change in methodology. Liggett contends that the retroactive change from gross to net unit amounts is impermissible for several reasons, including: |
| use of net unit amounts is not required by the MSA (as reflected by, among other things, the use of gross unit amounts through 2005); | ||
| such a change is not authorized without the consent of affected parties to the MSA; | ||
| the MSA provides for four-year time limitation periods for revisiting calculations and determinations, which precludes recalculating Liggetts 1997 Market Share (and thus, Liggetts market share exemption); and | ||
| Liggett and others have relied upon the calculations based on gross unit amounts since 1998. |
The change in the method of calculation could result in Liggett owing, at a minimum, approximately $9,500, plus interest, of additional MSA payments for prior years, because the proposed change from gross to net units would serve to lower Liggetts market share exemption under the MSA. The Company estimates that future MSA payments would be at least approximately $2,250 higher if the method of calculation is changed. No amounts have been expensed or accrued in the accompanying condensed consolidated financial statements for any potential liability relating to the gross versus net dispute. There can be no assurance that Liggett will not be required to make additional material payments, which payments could adversely affect the Companys consolidated financial position, results of operations or cash flows. |
Litigation Challenging the MSA. In Freedom Holdings Inc. v. Cuomo, litigation pending in federal court in New York, certain importers of cigarettes allege that the MSA and certain related New York statutes violate federal antitrust and constitutional law. The district court granted New Yorks motion to dismiss the complaint for failure to state a claim. On appeal, the United States Court of Appeals for the Second Circuit held that if all of the |
21
allegations of the complaint were assumed to be true, plaintiffs had stated a claim for relief on antitrust grounds. In January 2009, the district court granted New Yorks motion for summary judgment, dismissing all claims brought by the plaintiffs, and dissolving the preliminary injunction. Plaintiffs appealed the decision. Oral argument on the appeal occurred in December 2009. A decision is pending. |
In Grand River Enterprises Six Nations, Ltd. v. King, another proceeding pending in federal court in New York, plaintiffs seek to enjoin the statutes enacted by New York and other states in connection with the MSA on the grounds that the statutes violate the Commerce Clause of the United States Constitution and federal antitrust laws. In September 2005, the United States Court of Appeals for the Second Circuit held that if all of the allegations of the complaint were assumed to be true, plaintiffs had stated a claim for relief and that the New York federal court had jurisdiction over the other defendant states. On remand, the trial court held that plaintiffs are unlikely to succeed on the merits. After discovery, the parties cross-moved for summary judgment; briefing concluded in December 2009 and oral argument took place in April 2010. |
Similar challenges to the MSA and MSA-related state statutes are pending in several other states. Liggett and the other cigarette manufacturers are not defendants in these cases. Litigation challenging the validity of the MSA, including claims that the MSA violates antitrust laws, has not been successful to date. |
In October 2008, Vibo Corporation, Inc., d/b/a General Tobacco (Vibo) commenced litigation in the United States District Court for the Western District of Kentucky against each of the Settling States and certain Participating Manufacturers, including Liggett and Vector Tobacco. Vibo alleged, among other things, that the market share exemptions (i.e., grandfathered shares) provided to certain SPMs under the MSA, including Liggett and Vector Tobacco, violate federal antitrust and constitutional law. In January 2009, the district court dismissed the complaint. In January 2010, the court entered final judgment in favor of the defendants. Vibo appealed to the United States Court of Appeals for the Sixth Circuit. |
Other State Settlements. The MSA replaces Liggetts prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Liggetts agreements with these states remain in full force and effect, and Liggett made various payments to these states under the agreements. These states settlement agreements with Liggett contained most favored nation provisions which could reduce Liggetts payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on each of these four states settlements with United States Tobacco Company, Liggetts payment obligations to those states had been eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each states respective settlement with the other major tobacco companies. Therefore, Liggetts non-economic obligations to all states and territories are now defined by the MSA. |
In 2003, in order to resolve any potential issues with Minnesota as to Liggetts ongoing economic settlement obligations, Liggett negotiated a $100 a year payment to Minnesota, to be paid any year cigarettes manufactured by Liggett are sold in that state. In 2004, the Attorneys General for Florida, Mississippi and Texas advised Liggett that they believed that Liggett had failed to make required payments under the respective settlement agreements with these states from 1998 through 2003 and that additional payments may be due for subsequent years. Liggett believes the states allegations are without merit, based, among other things, on the language of the most favored nation provisions of the settlement agreements. Liggett has recently entered into a Memorandum of Understanding with Florida providing for a good faith payment by Liggett of $250. The parties have agreed to non-binding mediation of the dispute. There can be no assurance that Liggett will resolve these matters or that Liggett will not be required to make additional material payments, which payments could adversely affect the Companys consolidated financial position, results of operations or cash flows. |
22
Cautionary Statement. Management is not able to predict the outcome of the litigation pending or threatened against Liggett. Litigation is subject to many uncertainties. For example, the jury in the Lukacs case, an Engle progeny case tried in 2002, awarded $24,835 in compensatory damages plus interest against Liggett and two other defendants and found Liggett 50% responsible for the damages. The verdict was affirmed on appeal. Liggett has paid its share of the damages award and settled plaintiffs claim for interest and attorneys fees. Accordingly, this case is now concluded. Liggett has been found liable in four other Engle progeny cases, which are currently on appeal or will be appealed. As a result of the Engle decision, approximately 8,284 former Engle class members have claims pending against the Company and Liggett and other cigarette manufacturers. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may enter into discussions in an attempt to settle particular cases if it believes it is in its best interest to do so. |
Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. An unfavorable outcome of a pending smoking and health case could encourage the commencement of additional similar litigation, or could lead to multiple adverse decisions in the Engle progeny cases. Management is unable to make a reasonable estimate with respect to the amount or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its condensed consolidated financial statements for unfavorable outcomes. The complaints filed in these cases rarely detail alleged damages. Typically, the claims set forth in an individuals complaint against the tobacco industry seek money damages in an amount to be determined by a jury, plus punitive damages and costs. |
The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional similar litigation or legislation. |
It is possible that the Companys consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation. |
Liggetts and Vector Tobaccos management are unaware of any material environmental conditions affecting their existing facilities. Liggetts and Vector Tobaccos management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material effect on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco. |
Other Matters: |
In February 2004, Liggett Vector Brands and another cigarette manufacturer entered into a five year agreement with a subsidiary of the American Wholesale Marketers Association to support a program to permit certain tobacco distributors to secure, on reasonable terms, tax stamp bonds required by state and local governments for the distribution of cigarettes. This agreement has been extended through February 2014. Under the agreement, Liggett Vector Brands has agreed to pay a portion of losses, if any, incurred by the surety under the bond program, with a maximum loss exposure of $500 for Liggett Vector Brands. To secure its potential obligations under the agreement, Liggett Vector Brands has delivered to the subsidiary of the association a $100 letter of credit and agreed to fund up to an additional $400. Liggett Vector Brands has incurred no losses to date under this agreement, and the Company believes the fair value of Liggett Vector Brands obligation under the agreement was immaterial at June 30, 2010. |
In December 2009, a complaint was filed against Liggett in Alabama state court by the estate of a woman who died, in 2007, in a house fire allegedly caused by the ignition of contents of the house by a Liggett cigarette. |
23
Plaintiff is suing under the Alabama Extended Manufacturers Liability Doctrine and for breach of warranty and negligence. The plaintiff seeks both punitive and compensatory damages. In January 2010, Liggett removed the case to federal court. In February 2010, Liggett filed a motion to dismiss the case and plaintiff filed a motion to remand. A decision on both motions is pending. |
There may be several other proceedings, lawsuits and claims pending against the Company and certain of its consolidated subsidiaries unrelated to tobacco or tobacco product liability. Management is of the opinion that the liabilities, if any, ultimately resulting from such other proceedings, lawsuits and claims should not materially affect the Companys financial position, results of operations or cash flows. |
6. | INCOME TAXES |
The Companys provision for income taxes in interim periods is based on an estimated annual effective income tax rate derived, in part, from estimated annual pre-tax results from ordinary operations. The annual effective income tax rate is reviewed and, if necessary, adjusted on a quarterly basis. |
The Companys income tax expense consisted of the following: |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Income (loss) before provision for
income taxes |
$ | 30,602 | $ | (14,284 | ) | $ | 49,462 | $ | (8,846 | ) | ||||||
Income tax expense (benefit)
using estimated annual effective
income
tax rate |
11,751 | (6,138 | ) | 18,959 | (3,800 | ) | ||||||||||
Changes in effective tax rates |
(214 | ) | (800 | ) | | (800 | ) | |||||||||
Impact of discrete items, net |
| 600 | | 600 | ||||||||||||
Reduction of valuation allowance |
| | (500 | ) | | |||||||||||
Reversal of unrecognized
tax benefits |
(158 | ) | | (158 | ) | | ||||||||||
Income tax expense (benefit) |
$ | 11,379 | $ | (6,338 | ) | $ | 18,301 | $ | (4,000 | ) | ||||||
The Company recorded a benefit of $0 and $500 for the three and six months ended June 30, 2010 resulting from the reduction of a previously established valuation allowance of a deferred tax asset. The valuation allowance was reduced for the recognition of state tax net operating losses at Vector Tobacco Inc. after evaluating the impact of the negative and positive evidence that such asset would be realized. |
The discrete item for the three and six months ended June 30, 2009 related to the impact of the Companys loss on extinguishment of debt due to differences in the Companys marginal tax rate and its anticipated effective annual income tax rate at June 30, 2009. |
7. | NEW VALLEY LLC |
The components of Investments in non-consolidated real estate businesses were as follows: |
June 30, 2010 | December 31, 2009 | |||||||
Douglas Elliman Realty, LLC |
$ | 42,680 | $ | 36,086 | ||||
Aberdeen Townhomes LLC |
277 | 1,248 | ||||||
New Valley Oaktree Chelsea Eleven LLC |
13,154 | 12,232 | ||||||
Investments in non-consolidated real
estate businesses |
$ | 56,111 | $ | 49,566 | ||||
24
Residential Brokerage Business. New Valley recorded income of $7,207 and $1,810 for the three months ended June 30, 2010 and 2009, respectively, and income of $11,778 and $615 for the six months ended June 30, 2010 and 2009, respectively, associated with Douglas Elliman Realty, LLC. New Valley received cash distributions from Douglas Elliman Realty, LLC of $3,224 and $2,049 for the three months ended June 30, 2010 and 2009, respectively, and $5,185 and $3,476 for the six months ended June 30, 2010 and 2009, respectively. | ||
The summarized financial information of Douglas Elliman Realty, LLC is as follows: |
June 30, 2010 | December 31, 2009 | |||||||
Cash |
$ | 41,247 | $ | 26,920 | ||||
Other current assets |
7,769 | 6,664 | ||||||
Property, plant and equipment, net |
13,699 | 13,498 | ||||||
Trademarks |
21,663 | 21,663 | ||||||
Goodwill |
38,361 | 38,601 | ||||||
Other intangible assets, net |
1,477 | 742 | ||||||
Other non-current assets |
2,848 | 2,871 | ||||||
Notes payable current |
524 | 776 | ||||||
Current portion of notes payable to member -
Prudential Real Estate Financial Services
of America, Inc. |
| 2,487 | ||||||
Current portion of notes payable
to member New Valley |
| 2,487 | ||||||
Other current liabilities |
24,046 | 20,724 | ||||||
Notes payable long term |
1,067 | 2,136 | ||||||
Other long-term liabilities |
10,422 | 7,747 | ||||||
Members equity |
91,005 | 74,602 |
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Revenues |
$ | 98,518 | $ | 60,373 | $ | 175,179 | $ | 109,329 | ||||||||
Costs and expenses |
83,653 | 55,766 | 150,828 | 106,326 | ||||||||||||
Depreciation expense |
865 | 1,134 | 1,765 | 2,333 | ||||||||||||
Amortization expense |
88 | 64 | 165 | 128 | ||||||||||||
Other income |
441 | | 838 | | ||||||||||||
Interest expense, net |
167 | 602 | 445 | 1,293 | ||||||||||||
Income tax expense (benefit) |
435 | (55 | ) | 706 | (365 | ) | ||||||||||
Net income (loss) |
$ | 13,751 | $ | 2,862 | $ | 22,108 | $ | (386 | ) | |||||||
Aberdeen Townhomes LLC. In January 2010, Aberdeen sold one of its four townhomes and the mortgage of approximately $4,550 was retired. The Company received a preferred return distribution of approximately $971 in connection with the sale. In addition, Aberdeen received $375 in August 2010 from escrow on the January 2010 sale. Mortgages on the three remaining Aberdeen townhomes had a balance of approximately $27,400 as of June 30, 2010. These mortgages matured during 2009 and are in default. Aberdeen is in discussions with the lender related to the three remaining mortgages which are in default. There can be no assurance that an agreement will be reached. | ||
The Companys maximum exposure to loss on its investment in Aberdeen is $277 at June 30, 2010. |
25
New Valley Oaktree Chelsea Eleven, LLC. A subsidiary of New Valley is operating as an investment vehicle for the Chelsea Eleven LLC real estate development project. Chelsea sold 16 and 19 condominium units during the three and six months ended June 30, 2010, respectively. | ||
As of August 4, 2010, 30 of 54 condominium units in the Chelsea Eleven LLC real estate development had closed. As of June 30, 2010, Chelsea Eleven LLC had approximately $70,261 of total assets and $53,895 of total liabilities, excluding amounts owed to New Valley Oaktree Chelsea Eleven LLC (approximately $86,833 at June 30, 2010). | ||
Chelsea Eleven LLC retired its construction loan during the second quarter of 2010 from the proceeds of the sales of units. In addition, on July 1, 2010, Chelsea Eleven LLC borrowed $47,100, which is due in July 1, 2012, bearing interest at 14% per annum. The proceeds were used to retire Chelseas then outstanding mezzanine debt (approximately $37,200) and for other working capital purposes. | ||
As of June 30, 2010, the Company had lent an additional $1,141 to New Valley Oaktree Chelsea Eleven LLC. The Companys maximum exposure to loss on its investment in New Valley Oaktree Chelsea Eleven LLC is $13,154 at June 30, 2010. | ||
Investment in Escena: | ||
The components of the Companys investment in Escena are as follows: |
June 30, | December 31, | |||||||
2010 | 2009 | |||||||
Land and land improvements |
$ | 11,112 | $ | 11,126 | ||||
Building and building improvements |
1,426 | 1,154 | ||||||
Other |
1,123 | 1,038 | ||||||
13,661 | 13,318 | |||||||
Less accumulated depreciation |
(218 | ) | (74 | ) | ||||
$ | 13,443 | $ | 13,244 | |||||
The Company recorded an operating loss of $164 for the three months ended June 30, 2010 and income of approximately $118 for the six months ended June 30, 2010 from Escena. |
8. | INVESTMENTS AND FAIR VALUE MEASUREMENTS |
The Companys recurring financial assets and liabilities subject to fair value measurements are as follows: |
Fair Value Measurements as of June 30, 2010 | ||||||||||||||||
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | Significant | ||||||||||||||
Identical | Observable | Unobservable | ||||||||||||||
Assets | Inputs | Inputs | ||||||||||||||
Description | Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Assets: |
||||||||||||||||
Money market funds |
$ | 272,598 | $ | 272,598 | $ | | $ | | ||||||||
Certificates of deposit |
2,768 | | 2,768 | | ||||||||||||
Bonds |
2,728 | 2,728 | | | ||||||||||||
Investment securities
available for sale |
70,732 | 66,618 | 4,114 | | ||||||||||||
Total |
$ | 348,826 | $ | 341,944 | $ | 6,882 | $ | | ||||||||
Liabilities: |
||||||||||||||||
Fair value of derivatives
embedded within
convertible debt |
$ | 141,941 | $ | | $ | | $ | 141,941 | ||||||||
26
Fair Value Measurements as of December 31, 2009 | ||||||||||||||||
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | Significant | ||||||||||||||
Identical | Observable | Unobservable | ||||||||||||||
Assets | Inputs | Inputs | ||||||||||||||
Description | Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Assets: |
||||||||||||||||
Money market funds |
$ | 199,423 | $ | 199,423 | $ | | $ | | ||||||||
Certificates of deposit |
2,785 | | 2,785 | | ||||||||||||
Bonds |
3,128 | 3,128 | | | ||||||||||||
Investment
securities available for sale |
51,742 | 38,706 | 13,036 | | ||||||||||||
Total |
$ | 257,078 | $ | 241,257 | $ | 15,821 | $ | | ||||||||
Liabilities: |
||||||||||||||||
Fair value of derivatives
embedded within
convertible debt |
$ | 153,016 | $ | | $ | | $ | 153,016 | ||||||||
The fair value of investment securities available for sale included in Level 1 are based on quoted market prices from various stock exchanges. The Level 2 investment securities available for sale were not registered and do not have direct market quotes. | ||
The fair value of derivatives embedded within convertible debt were derived using a valuation model and have been classified as Level 3. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads for secured to unsecured debt, unsecured to subordinated debt and subordinated debt to preferred stock to determine the fair value of the derivatives embedded within the convertible debt. The changes in fair value of derivatives embedded within convertible debt are presented on the Condensed Consolidated Statements of Operations. | ||
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. | ||
The Companys nonrecurring nonfinancial assets subject to fair value measurements are as follows: |
Fair Value Measurements as of June 30, 2009 Using: | ||||||||||||||||||||
Six | Quoted Prices | |||||||||||||||||||
Months Ended | in Active | Significant | ||||||||||||||||||
June 30, | Markets for | Other | Significant | |||||||||||||||||
2009 | Identical | Observable | Unobservable | |||||||||||||||||
Impairment | Assets | Inputs | Inputs | |||||||||||||||||
Description | Charge | Total | (Level 1) | (Level 2) | (Level 3) | |||||||||||||||
Assets: |
||||||||||||||||||||
Investment in real
estate |
$ | 5,000 | $ | 12,204 | $ | | $ | | $ | 12,204 | ||||||||||
Investment in non-
consolidated real
estate businesses |
3,500 | 3,000 | | | 3,000 | |||||||||||||||
Total |
$ | 8,500 | $ | 15,204 | $ | | $ | | $ | 15,204 | ||||||||||
27
The Company estimated the fair value of its investment in Escena and non-consolidated real estate using observable inputs such as market pricing based on recent events, however, significant judgment was required to select certain inputs from observed market data. The decrease in the mortgage receivable and the non-consolidated real estate were attributed to the decline in the New York and California real estate markets due to various factors including downward pressure on housing prices, the impact of the recent contraction in the subprime and mortgage markets generally and a large inventory of unsold homes at the same time that sales volumes were decreasing. |
9. | SEGMENT INFORMATION |
As a result of the suspension of the marketing of low nicotine and nicotine-free cigarette products by Vector Tobacco and significant reductions in Vector Tobaccos related research activities, the Company has reevaluated its operating segments and combined the Liggett and Vector Tobacco businesses into a single Tobacco segment. The Companys significant business segments for the three and six months ended June 30, 2010 and 2009, respectively, were Tobacco and Real Estate. The Tobacco segment consists of the manufacture and sale of cigarettes and the research related to reduced risk products. The Real Estate segment includes the Companys investment in Escena and investments in non-consolidated real estate businesses. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Prior period segment information has been recast to conform to the current presentation. | ||
Financial information for the Companys operations before taxes for the three and six months ended June 30, 2010 and 2009, respectively, follows: |
Real | Corporate | |||||||||||||||
Tobacco | Estate | and Other | Total | |||||||||||||
Three months ended June 30, 2010 |
||||||||||||||||
Revenues |
$ | 268,460 | | | $ | 268,460 | ||||||||||
Operating income (loss) |
26,027 | (1) | (164 | ) | (4,786 | ) | 21,077 | |||||||||
Depreciation and amortization |
2,119 | 76 | 580 | 2,775 | ||||||||||||
Equity income from non-consolidated
real estate businesses |
| 7,207 | | 7,207 | ||||||||||||
Three months ended June 30, 2009 |
||||||||||||||||
Revenues |
$ | 206,794 | | | $ | 206,794 | ||||||||||
Operating income (loss) |
41,948 | | (3,101 | ) | 38,847 | |||||||||||
Depreciation and amortization |
1,998 | | 527 | 2,525 | ||||||||||||
Equity income from non-consolidated
real estate businesses |
| 1,811 | | 1,811 | ||||||||||||
Six months ended June 30, 2010 |
||||||||||||||||
Revenues |
$ | 490,547 | | | $ | 490,547 | ||||||||||
Operating income (loss) |
60,959 | (1) | 118 | (8,982 | ) | 52,095 | ||||||||||
Equity income from non-consolidated
real estate businesses |
| 11,778 | | 11,778 | ||||||||||||
Depreciation and amortization |
4,192 | 144 | 1,159 | 5,495 | ||||||||||||
Capital expenditures |
8,639 | 560 | 45 | 9,244 | ||||||||||||
Six months ended June 30, 2009 |
||||||||||||||||
Revenues |
$ | 328,010 | | | $ | 328,010 | ||||||||||
Operating income (loss) |
77,573 | (2) | | (7,566 | ) | 70,007 | ||||||||||
Equity income from non-consolidated
real estate businesses |
| 816 | | 816 | ||||||||||||
Depreciation and amortization |
4,011 | | 1,107 | 5,118 | ||||||||||||
Capital expenditures |
1,409 | | | 1,409 |
(1) | Operating income includes litigation judgment expense of $14,361. | |
(2) | Operating income includes a gain of $5,000 on the Philip Morris brand transaction completed February 2009 and restructuring costs of $1,000. |
28
10. | CONDENSED CONSOLIDATING FINANCIAL INFORMATION |
The accompanying condensed consolidating financial information has been prepared and presented pursuant to Securities and Exchange Commission Regulation S-X, Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered. Each of the subsidiary guarantors are 100% owned, directly or indirectly, by the Company, and all guarantees are full and unconditional and joint and several. The Companys investments in its consolidated subsidiaries are presented under the equity method of accounting. |
29
June 30, 2010 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
ASSETS: |
||||||||||||||||||||
Current assets: |
||||||||||||||||||||
Cash and cash equivalents |
$ | 271,400 | $ | 13,713 | $ | 417 | $ | | $ | 285,530 | ||||||||||
Investment securities available for sale |
70,732 | | | | 70,732 | |||||||||||||||
Accounts receivable trade |
| 6,742 | 1 | | 6,743 | |||||||||||||||
Intercompany receivables |
3 | | | (3 | ) | | ||||||||||||||
Inventories |
| 100,749 | | | 100,749 | |||||||||||||||
Deferred income taxes |
12,040 | 3,562 | | | 15,602 | |||||||||||||||
Income taxes receivable |
10,534 | 10,046 | | (20,580 | ) | | ||||||||||||||
Restricted assets |
| 2,979 | | | 2,979 | |||||||||||||||
Other current assets |
533 | 2,794 | 153 | | 3,480 | |||||||||||||||
Total current assets |
365,242 | 140,585 | 571 | (20,583 | ) | 485,815 | ||||||||||||||
Property, plant and equipment, net |
615 | 45,726 | | | 46,341 | |||||||||||||||
Investment in Escena, net |
| | 13,443 | | 13,443 | |||||||||||||||
Long-term investments accounted for at cost |
45,134 | | 837 | | 45,971 | |||||||||||||||
Long-term investments accounted
for under the equity method |
10,900 | | | | 10,900 | |||||||||||||||
Investments in non- consolidated real estate businesses |
| | 56,111 | | 56,111 | |||||||||||||||
Investments in consolidated subsidiaries |
239,969 | | | (239,969 | ) | | ||||||||||||||
Restricted assets |
2,668 | 3,045 | | | 5,713 | |||||||||||||||
Deferred income taxes |
26,935 | 106,259 | 9,247 | (104,779 | ) | 37,662 | ||||||||||||||
Intangible asset |
| 107,511 | | | 107,511 | |||||||||||||||
Prepaid pension costs |
| 9,480 | | | 9,480 | |||||||||||||||
Other assets |
16,524 | 14,515 | | | 31,039 | |||||||||||||||
Total assets |
$ | 707,987 | $ | 427,121 | $ | 80,209 | $ | (365,331 | ) | $ | 849,986 | |||||||||
LIABILITIES AND STOCKHOLDERS DEFICIENCY: |
||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||
Current portion of notes payable and long-term debt |
$ | | $ | 31,855 | $ | 119 | $ | | $ | 31,974 | ||||||||||
Current portion of employee benefits |
| 1,029 | | | 1,029 | |||||||||||||||
Accounts payable |
646 | 5,176 | 72 | | 5,894 | |||||||||||||||
Intercompany payables |
| 3 | | (3 | ) | | ||||||||||||||
Accrued promotional expenses |
| 13,006 | | | 13,006 | |||||||||||||||
Income taxes payable, net |
| 612 | 35,355 | (20,580 | ) | 15,387 | ||||||||||||||
Accrued excise and payroll taxes payable, net |
| 15,787 | | | 15,787 | |||||||||||||||
Settlement accruals |
| 60,525 | | | 60,525 | |||||||||||||||
Deferred income taxes |
22,031 | 1,934 | | | 23,965 | |||||||||||||||
Accrued interest |
16,959 | | | | 16,959 | |||||||||||||||
Other current liabilities |
4,332 | 7,417 | 699 | | 12,448 | |||||||||||||||
Total current liabilities |
43,968 | 137,344 | 36,245 | (20,583 | ) | 196,974 | ||||||||||||||
Notes payable, long-term debt and other obligations, less
current portion |
398,786 | 14,518 | 420 | | 413,724 | |||||||||||||||
Fair value of derivatives embedded within convertible debt |
141,941 | | | | 141,941 | |||||||||||||||
Non-current employee benefits |
14,025 | 21,110 | | | 35,135 | |||||||||||||||
Deferred income taxes |
128,609 | 25,372 | 59 | (104,779 | ) | 49,261 | ||||||||||||||
Other liabilities |
256 | 31,789 | 504 | | 32,549 | |||||||||||||||
Total liabilities |
727,585 | 230,133 | 37,228 | (125,362 | ) | 869,584 | ||||||||||||||
Commitments and contingencies |
| | | | | |||||||||||||||
Stockholders deficiency |
(19,598 | ) | 196,988 | 42,981 | (239,969 | ) | (19,598 | ) | ||||||||||||
Total liabilities and stockholders
deficiency |
$ | 707,987 | $ | 427,121 | $ | 80,209 | $ | (365,331 | ) | $ | 849,986 | |||||||||
30
December 31, 2009 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
ASSETS: |
||||||||||||||||||||
Current assets: |
||||||||||||||||||||
Cash and cash equivalents |
$ | 204,133 | $ | 5,004 | $ | 317 | $ | | $ | 209,454 | ||||||||||
Investment securities available for sale |
51,743 | | | | 51,743 | |||||||||||||||
Accounts receivable trade |
| 8,089 | 9 | | 8,098 | |||||||||||||||
Intercompany receivables |
| 43 | | (43 | ) | | ||||||||||||||
Inventories |
| 98,485 | 1 | | 98,486 | |||||||||||||||
Deferred income taxes |
11,240 | 2,914 | | | 14,154 | |||||||||||||||
Income taxes receivable |
| 26,086 | | (26,086 | ) | | ||||||||||||||
Restricted assets |
| 3,138 | | | 3,138 | |||||||||||||||
Other current assets |
497 | 3,512 | 126 | | 4,135 | |||||||||||||||
Total current assets |
267,613 | 147,271 | 453 | (26,129 | ) | 389,208 | ||||||||||||||
Property, plant and equipment, net |
623 | 42,363 | | | 42,986 | |||||||||||||||
Investment in Escena, net |
| | 13,244 | | 13,244 | |||||||||||||||
Long-term investments accounted for
at cost |
49,486 | | 837 | | 50,323 | |||||||||||||||
Investments in non- consolidated
real estate businesses |
| | 49,566 | | 49,566 | |||||||||||||||
Investments in consolidated subsidiaries |
282,010 | | | (282,010 | ) | | ||||||||||||||
Restricted assets |
2,685 | 2,150 | | | 4,835 | |||||||||||||||
Deferred income taxes |
28,729 | 94,088 | 9,667 | (92,646 | ) | 39,838 | ||||||||||||||
Intangible asset |
| 107,511 | | | 107,511 | |||||||||||||||
Prepaid pension costs |
| 8,994 | | | 8,994 | |||||||||||||||
Other assets |
14,942 | 14,095 | | | 29,037 | |||||||||||||||
Total assets |
$ | 646,088 | $ | 416,472 | $ | 73,767 | $ | (400,785 | ) | $ | 735,542 | |||||||||
LIABILITIES AND STOCKHOLDERS DEFICIENCY: |
||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||
Current portion of
notes payable and long-term
debt |
$ | | $ | 21,773 | $ | 116 | $ | | $ | 21,889 | ||||||||||
Current portion of employee
benefits |
| 1,029 | | | 1,029 | |||||||||||||||
Accounts payable |
1,490 | 2,763 | 102 | | 4,355 | |||||||||||||||
Intercompany payables |
43 | | | (43 | ) | | ||||||||||||||
Accrued promotional expenses |
| 12,745 | | | 12,745 | |||||||||||||||
Income taxes payable, net |
14,472 | 547 | 30,991 | (26,086 | ) | 19,924 | ||||||||||||||
Accrued excise and payroll taxes
payable, net |
| 24,088 | 5 | | 24,093 | |||||||||||||||
Settlement accruals |
| 18,803 | | | 18,803 | |||||||||||||||
Deferred income taxes |
14,992 | 2,262 | | | 17,254 | |||||||||||||||
Accrued interest |
13,840 | | | | 13,840 | |||||||||||||||
Other current liabilities |
6,039 | 8,427 | 610 | | 15,076 | |||||||||||||||
Total current liabilities |
50,876 | 92,437 | 31,824 | (26,129 | ) | 149,008 | ||||||||||||||
Notes payable, long-term debt and
other obligations, less current
portion |
319,588 | 14,853 | 479 | | 334,920 | |||||||||||||||
Fair value of derivatives embedded
within convertible debt |
153,016 | | | | 153,016 | |||||||||||||||
Non-current employee benefits |
13,301 | 20,946 | | | 34,247 | |||||||||||||||
Deferred income taxes |
113,667 | 24,040 | 59 | (92,646 | ) | 45,120 | ||||||||||||||
Other liabilities |
322 | 22,763 | 828 | | 23,913 | |||||||||||||||
Total liabilities |
650,770 | 175,039 | 33,190 | (118,775 | ) | 740,224 | ||||||||||||||
Commitments and contingencies |
| | | | | |||||||||||||||
Stockholders deficiency |
(4,682 | ) | 241,433 | 40,577 | (282,010 | ) | (4,682 | ) | ||||||||||||
Total liabilities and
stockholders
deficiency |
$ | 646,088 | $ | 416,472 | $ | 73,767 | $ | (400,785 | ) | $ | 735,542 | |||||||||
31
Three Months Ended June 30, 2010 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Revenues |
$ | | $ | 268,460 | $ | | $ | | $ | 268,460 | ||||||||||
Expenses: |
||||||||||||||||||||
Cost of goods sold |
| 210,994 | | | 210,994 | |||||||||||||||
Operating, selling, administrative and
general expenses |
5,916 | 15,884 | 228 | | 22,028 | |||||||||||||||
Litigation judgment
expense |
| 14,361 | | | 14,361 | |||||||||||||||
Management fee expense |
| 2,131 | | (2,131 | ) | | ||||||||||||||
Operating (loss) income |
(5,916 | ) | 25,090 | (228 | ) | 2,131 | 21,077 | |||||||||||||
Other income (expenses): |
||||||||||||||||||||
Interest expense |
(20,540 | ) | (219 | ) | (11 | ) | | (20,770 | ) | |||||||||||
Changes in fair value of derivatives
embedded within convertible debt |
13,789 | | | | 13,789 | |||||||||||||||
Equity income on non-consolidated real
estate businesses |
| | 7,207 | | 7,207 | |||||||||||||||
Gain on investment
securities
available for
sale |
6,447 | | | | 6,447 | |||||||||||||||
Equity income in consolidated subsidiaries |
33,553 | | | (33,553 | ) | | ||||||||||||||
Management fee income |
2,131 | | | (2,131 | ) | | ||||||||||||||
Other, net |
2,844 | 8 | | | 2,852 | |||||||||||||||
Income before provision for income taxes |
32,308 | 24,879 | 6,968 | (33,553 | ) | 30,602 | ||||||||||||||
Income tax (expense) benefit |
(13,085 | ) | 4,535 | (2,829 | ) | | (11,379 | ) | ||||||||||||
Net income |
$ | 19,223 | $ | 29,414 | $ | 4,139 | $ | (33,553 | ) | $ | 19,223 | |||||||||
32
Three Months Ended June 30, 2009 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Revenues |
$ | | $ | 206,794 | $ | | $ | | $ | 206,794 | ||||||||||
Expenses: |
||||||||||||||||||||
Cost of goods sold |
| 147,764 | | | 147,764 | |||||||||||||||
Operating, selling, administrative and general expenses |
4,502 | 15,870 | (189 | ) | | 20,183 | ||||||||||||||
Management fee expense |
| 2,056 | | (2,056 | ) | | ||||||||||||||
Operating income (loss) |
(4,502 | ) | 41,104 | 189 | 2,056 | 38,847 | ||||||||||||||
Other income (expenses): |
||||||||||||||||||||
Interest expense |
(16,838 | ) | (248 | ) | | | (17,086 | ) | ||||||||||||
Loss on exchanges |
(18,444 | ) | | | | (18,444 | ) | |||||||||||||
Changes in fair value of derivatives embedded within
convertible debt |
(19,488 | ) | | | | (19,488 | ) | |||||||||||||
Equity income on non-consolidated real estate
businesses |
| | 1,811 | | 1,811 | |||||||||||||||
Equity income in consolidated subsidiaries |
26,253 | | | (26,253 | ) | | ||||||||||||||
Management fee income |
2,056 | | | (2,056 | ) | | ||||||||||||||
Other, net |
62 | 14 | | | 76 | |||||||||||||||
Income (loss) before provision for income taxes |
(30,901 | ) | 40,870 | 2,000 | (26,253 | ) | (14,284 | ) | ||||||||||||
Income tax benefit (expense) |
22,955 | (15,656 | ) | (961 | ) | | 6,338 | |||||||||||||
Net income (loss) |
$ | (7,946 | ) | $ | 25,214 | $ | 1,039 | $ | (26,253 | ) | $ | (7,946 | ) | |||||||
33
Six Months Ended June 30, 2010 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Revenues |
$ | | $ | 490,547 | $ | | $ | | $ | 490,547 | ||||||||||
Expenses: |
||||||||||||||||||||
Cost of goods sold |
| 380,905 | | | 380,905 | |||||||||||||||
Operating, selling,
administrative and
general expenses |
11,134 | 32,079 | (27 | ) | | 43,186 | ||||||||||||||
Litigation judgment
expense |
| 14,361 | | | 14,361 | |||||||||||||||
Management fee expense |
| 4,261 | | (4,261 | ) | | ||||||||||||||
Operating (loss)
income |
(11,134 | ) | 58,941 | 27 | 4,261 | 52,095 | ||||||||||||||
Other income (expenses): |
||||||||||||||||||||
Interest expense |
(39,115 | ) | (438 | ) | (22 | ) | | (39,575 | ) | |||||||||||
Changes in fair value
of derivatives
embedded within
convertible debt |
11,075 | | | | 11,075 | |||||||||||||||
Equity income on
non-consolidated
real estate
businesses |
| | 11,778 | | 11,778 | |||||||||||||||
Gain on investment
securities
available for
sale |
11,111 | | | | 11,111 | |||||||||||||||
Equity income in
consolidated
subsidiaries |
60,921 | | | (60,921 | ) | | ||||||||||||||
Management fee income |
4,261 | | | (4,261 | ) | | ||||||||||||||
Other, net |
2,962 | 16 | | | 2,978 | |||||||||||||||
Income before
provision for income
taxes |
40,081 | 58,519 | 11,783 | (60,921 | ) | 49,462 | ||||||||||||||
Income tax
(expense) benefit |
(8,920 | ) | (4,597 | ) | (4,784 | ) | | (18,301 | ) | |||||||||||
Net income |
$ | 31,161 | $ | 53,922 | $ | 6,999 | $ | (60,921 | ) | $ | 31,161 | |||||||||
34
Six Months Ended June 30, 2009 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Revenues |
$ | | $ | 328,010 | $ | | $ | | $ | 328,010 | ||||||||||
Expenses: |
||||||||||||||||||||
Cost of goods sold |
| 220,290 | | | 220,290 | |||||||||||||||
Operating, selling,
administrative and
general expenses |
9,652 | 31,860 | 201 | | 41,713 | |||||||||||||||
Gain on brand
transaction |
| (5,000 | ) | | | (5,000 | ) | |||||||||||||
Restructuring
charges |
| 1,000 | | | 1,000 | |||||||||||||||
Management fee expense |
| 4,112 | | (4,112 | ) | | ||||||||||||||
Operating income
(loss) |
(9,652 | ) | 75,748 | (201 | ) | 4,112 | 70,007 | |||||||||||||
Other income (expenses): |
||||||||||||||||||||
Interest expense |
(32,632 | ) | (528 | ) | | | (33,160 | ) | ||||||||||||
Loss on exchanges |
(18,444 | ) | | | | (18,444 | ) | |||||||||||||
Changes in fair value
of derivatives
embedded within
convertible debt |
(19,791 | ) | | | | (19,791 | ) | |||||||||||||
Impairment charges
on investments |
| | (8,500 | ) | | (8,500 | ) | |||||||||||||
Equity income from
non-consolidated
real estate
businesses |
| | 816 | | 816 | |||||||||||||||
Equity income in
consolidated
subsidiaries |
41,752 | | | (41,752 | ) | | ||||||||||||||
Management fee income |
4,112 | | | (4,112 | ) | | ||||||||||||||
Other, net |
137 | 89 | | | 226 | |||||||||||||||
Income (loss) before
provision for income
taxes |
(34,518 | ) | 75,309 | (7,885 | ) | (41,752 | ) | (8,846 | ) | |||||||||||
Income tax
benefit (expense) |
29,672 | (28,775 | ) | 3,103 | | 4,000 | ||||||||||||||
Net income (loss) |
$ | (4,846 | ) | $ | 46,534 | $ | (4,782 | ) | $ | (41,752 | ) | $ | (4,846 | ) | ||||||
35
Six Months Ended June 30, 2010 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Net cash provided by (used in)
operating activities |
$ | 51,784 | $ | 107,284 | $ | 2,480 | $ | (105,696 | ) | $ | 55,852 | |||||||||
Cash flows from investing
activities: |
||||||||||||||||||||
Sale or maturity of investment
securities |
15,433 | | | | 15,433 | |||||||||||||||
Purchase of investment
securities |
(7,414 | ) | | | | (7,414 | ) | |||||||||||||
Proceeds from sale of or
liquidation of long-term
investments |
1,001 | | | | 1,001 | |||||||||||||||
Purchase of long-term
investment |
(5,000 | ) | | | | (5,000 | ) | |||||||||||||
Investment in non-
consolidated real estate
businesses |
| | (924 | ) | | (924 | ) | |||||||||||||
Distributions from
non-consolidated real estate
businesses |
| | 3,539 | | 3,539 | |||||||||||||||
Increase in cash surrender
value of life insurance
policies |
(513 | ) | (16 | ) | | | (529 | ) | ||||||||||||
(Increase) decrease
in non-current restricted
assets |
17 | (895 | ) | | | (878 | ) | |||||||||||||
Issuance of notes
receivable |
(535 | ) | | | | (535 | ) | |||||||||||||
Proceeds from sale of fixed
assets |
| 3 | | | 3 | |||||||||||||||
Investments in
subsidiaries |
(2,325 | ) | | | 2,325 | | ||||||||||||||
Capital expenditures |
(262 | ) | (8,639 | ) | (343 | ) | | (9,244 | ) | |||||||||||
Net cash
(used in) provided by investing activities |
402 | (9,547 | ) | 2,272 | 2,325 | (4,548 | ) | |||||||||||||
Cash flows from
financing activities: |
||||||||||||||||||||
Proceeds from debt
issuance |
75,000 | 4,585 | | | 79,585 | |||||||||||||||
Deferred financing costs |
(2,582 | ) | | | | (2,582 | ) | |||||||||||||
Repayments of debt |
| (2,373 | ) | (56 | ) | | (2,429 | ) | ||||||||||||
Borrowings under revolver |
| 472,865 | | | 472,865 | |||||||||||||||
Repayments on revolver |
| (465,330 | ) | | | (465,330 | ) | |||||||||||||
Capital contributions received |
| 2,325 | | (2,325 | ) | | ||||||||||||||
Intercompany dividends paid |
| (101,100 | ) | (4,596 | ) | 105,696 | | |||||||||||||
Dividends and distributions
on common stock |
(57,919 | ) | | | | (57,919 | ) | |||||||||||||
Proceeds from exercise of
Vector options and warrants |
507 | | | | 507 | |||||||||||||||
Tax benefits from exercise of
Vector options and warrants |
75 | | | | 75 | |||||||||||||||
Net cash provided by (used in)
financing activities |
15,081 | (89,028 | ) | (4,652 | ) | 103,371 | 24,772 | |||||||||||||
Net decrease in cash and cash
equivalents |
67,267 | 8,709 | 100 | | 76,076 | |||||||||||||||
Cash and cash equivalents, beginning
of period |
204,133 | 5,004 | 317 | | 209,454 | |||||||||||||||
Cash and cash equivalents, end of
period |
$ | 271,400 | $ | 13,713 | $ | 417 | $ | | $ | 285,530 | ||||||||||
36
Six Months Ended June 30, 2009 | ||||||||||||||||||||
Subsidiary | Consolidated | |||||||||||||||||||
Parent/ | Subsidiary | Non- | Consolidating | Vector Group | ||||||||||||||||
Issuer | Guarantors | Guarantors | Adjustments | Ltd. | ||||||||||||||||
Net cash provided by operating
activities |
$ | 55,499 | $ | 55,892 | $ | 1,642 | $ | (60,480 | ) | $ | 52,553 | |||||||||
Cash flows from investing
activities: |
||||||||||||||||||||
Purchase of investment
securities |
(10,667 | ) | | | | (10,667 | ) | |||||||||||||
Proceeds from sale or
liquidation of long-term
investments |
1,407 | | | | 1,407 | |||||||||||||||
Distributions from
non-consolidated real estate
businesses |
| | 2,364 | | 2,364 | |||||||||||||||
Investments in
subsidiaries |
(2,050 | ) | | | 2,050 | | ||||||||||||||
Increase in cash surrender
value of life insurance
policies |
(425 | ) | (332 | ) | | | (757 | ) | ||||||||||||
(Increase) decrease in non-
current restricted assets |
(122 | ) | 568 | | | 446 | ||||||||||||||
Capital expenditures |
| (1,409 | ) | | | (1,409 | ) | |||||||||||||
Net cash (used in) provided by
investing activities |
(11,857 | ) | (1,173 | ) | 2,364 | 2,050 | (8,616 | ) | ||||||||||||
Cash flows from
financing activities: |
||||||||||||||||||||
Proceeds from debt
Issuance |
38,225 | 21 | | | 38,246 | |||||||||||||||
Repayments of debt |
| (3,052 | ) | | | (3,052 | ) | |||||||||||||
Deferred financing charges |
(210 | ) | (6 | ) | | | (216 | ) | ||||||||||||
Borrowings under revolver |
| 306,788 | | | 306,788 | |||||||||||||||
Repayments on revolver |
| (306,167 | ) | | | (306,167 | ) | |||||||||||||
Capital contributions received |
| 2,050 | | (2,050 | ) | | ||||||||||||||
Intercompany dividends paid |
| (56,475 | ) | (4,005 | ) | 60,480 | | |||||||||||||
Dividends and distributions
on common stock |
(58,310 | ) | | | | (58,310 | ) | |||||||||||||
Proceeds from exercise of
Vector options and warrants |
182 | | | | 182 | |||||||||||||||
Tax benefit of options
exercised |
13 | | | | 13 | |||||||||||||||
Net cash (used in) financing
activities |
(20,100 | ) | (56,841 | ) | (4,005 | ) | 58,430 | (22,516 | ) | |||||||||||
Net increase (decrease) in cash
and cash equivalents |
23,542 | (2,122 | ) | 1 | | 21,421 | ||||||||||||||
Cash and cash equivalents,
beginning of period |
200,066 | 11,039 | | | 211,105 | |||||||||||||||
Cash and cash equivalents, end of
period |
$ | 223,608 | $ | 8,917 | $ | 1 | $ | | $ | 232,526 | ||||||||||
37
| the manufacture and sale of cigarettes in the United States through our Liggett Group LLC, | ||
| research relating to reduced risk cigarette products and manufacture and sale of cigarettes through our Vector Tobacco Inc. subsidiary, and | ||
| the real estate business through our New Valley LLC subsidiary, which is seeking to acquire additional operating companies and real estate properties. New Valley owns 50% of Douglas Elliman Realty, LLC, which operates the largest residential brokerage company in the New York metropolitan area. |
| LIGGETT SELECT a leading brand in the deep discount category, | ||
| GRAND PRIX re-launched as a national brand in 2005, | ||
| EVE a leading brand of 120 millimeter cigarettes in the branded discount category, | ||
| PYRAMID the industrys first deep discount product with a brand identity re-launched in the second quarter of 2009, and | ||
| USA and various Partner Brands and private label brands. |
- 38 -
- 39 -
- 40 -
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | June 30, | June 30, | |||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Revenues: |
||||||||||||||||
Tobacco |
$ | 268,460 | $ | 206,794 | $ | 490,547 | $ | 328,010 | ||||||||
Operating income: |
||||||||||||||||
Tobacco |
$ | 26,027 | (1) | $ | 41,948 | $ | 60,959 | (1) | $ | 77,573 | (2) | |||||
Real Estate |
(164 | ) | | 118 | | |||||||||||
Corporate and other |
(4,786 | ) | (3,101 | ) | (8,982 | ) | (7,566 | ) | ||||||||
Total operating income |
$ | 21,077 | $ | 38,847 | $ | 52,095 | $ | 70,007 | ||||||||
(1) | Operating income includes litigation judgment expense of $14,361. | |
(2) | Operating income includes a gain of $5,000 on the Philip Morris brand transaction completed February 2009 and restructuring costs of $1,000. |
- 41 -
- 42 -
- 43 -
- 44 -
- 45 -
Indenture | June 30, | December 31, | ||||||||||
Covenant | Requirement | 2010 | 2009 | |||||||||
Consolidated EBITDA, as defined |
$ | 50,000 | $ | 183,737 | $ | 174,158 | ||||||
Leverage ratio, as defined |
<3.0 to 1 | 0.1 to 1 | 0.3 to 1 | |||||||||
Secured leverage ratio, as defined |
<1.5 to 1 | Negative | Negative |
- 46 -
- 47 -
- 48 -
| increases the number of health warnings required on cigarette and smokeless tobacco products, increases the size of warnings on packaging and in advertising, requires the FDA to develop graphic warnings for cigarette packages, and grants the FDA authority to require new warnings; | ||
| requires practically all tobacco product advertising to eliminate color and imagery and instead consist solely of black text on white background; | ||
| imposes new restrictions on the sale and distribution of tobacco products, including significant new restrictions on tobacco product advertising and promotion, as well as the use of brand and trade names; | ||
| bans the use of light, mild, low or similar descriptors on tobacco products; | ||
| bans the use of characterizing flavors in cigarettes other than tobacco or menthol; | ||
| gives the FDA the authority to impose tobacco product standards that are appropriate for the protection of the public health (by, for example, requiring reduction or elimination of the use of particular constituents or components, requiring product testing, or addressing other aspects of tobacco product construction, constituents, properties or labeling); | ||
| requires manufacturers to obtain FDA review and authorization for the marketing of certain new or modified tobacco products; | ||
| requires pre-market approval by the FDA for tobacco products represented (through labels, labeling, advertising, or other means) as presenting a lower risk of harm or tobacco-related disease; | ||
| requires manufacturers to report ingredients and harmful constituents and requires the FDA to disclose certain constituent information to the public; | ||
| mandates that manufacturers test and report on ingredients and constituents identified by the FDA as requiring such testing to protect the public health, and allows the FDA to require the disclosure of testing results to the public; | ||
| requires manufacturers to submit to the FDA certain information regarding the health, toxicological, behavioral or physiologic effects of tobacco products; | ||
| prohibits use of tobacco containing a pesticide chemical residue at a level greater than allowed under federal law; | ||
| requires the FDA to establish good manufacturing practices to be followed at tobacco manufacturing facilities; | ||
| requires tobacco product manufacturers (and certain other entities) to register with the FDA; | ||
| authorizes the FDA to require the reduction of nicotine (although it may not require the reduction of nicotine yields of a tobacco product to zero) and the potential reduction or elimination of other constituents, including menthol; | ||
| imposes (and allows the FDA to impose) various recordkeeping and reporting requirements on tobacco product manufacturers; and | ||
| grants the FDA the regulatory authority to impose broad additional restrictions. |
| a recommendation on modified risk applications; | ||
| a recommendation on the effects of tobacco product nicotine yield alteration and whether there is a threshold level below which nicotine yields do not produce dependence; | ||
| a report on the public health impact of the use of menthol in cigarettes; and | ||
| a report on the public health impact of dissolvable tobacco products. |
- 49 -
- 50 -
- 51 -
| economic outlook, | ||
| capital expenditures, | ||
| cost reduction, | ||
| new legislation, | ||
| cash flows, | ||
| operating performance, | ||
| litigation, | ||
| impairment charges and cost saving associated with restructurings of our tobacco operations, and | ||
| related industry developments (including trends affecting our business, financial condition and results of operations). |
- 52 -
| general economic and market conditions and any changes therein, due to acts of war and terrorism or otherwise, | ||
| impact of current crises in capital and credit markets, including any continued worsening, | ||
| governmental regulations and policies, | ||
| effects of industry competition, | ||
| impact of business combinations, including acquisitions and divestitures, both internally for us and externally in the tobacco industry, | ||
| impact of restructurings on our tobacco business and our ability to achieve any increases in profitability estimated to occur as a result of these restructurings, | ||
| impact of new legislation on our competitors payment obligations, results of operations and product costs, i.e. the impact of recent federal legislation eliminating the federal tobacco quota system and providing for regulation of tobacco products by the FDA, | ||
| impact of substantial increases in federal, state and local excise taxes, | ||
| uncertainty related to litigation and potential additional payment obligations for us under the Master Settlement Agreement and other settlement agreements with the states, and | ||
| risks inherent in our new product development initiatives. |
- 53 -
Reference is made to Note 5, incorporated herein by reference, to our condensed consolidated financial statements included elsewhere in this report which contains a general description of certain legal proceedings to which our company, VGR Holding, Liggett, Vector Tobacco, New Valley or their subsidiaries are a party and certain related matters. Reference is also made to Exhibit 99.1 for additional information regarding the pending smoking-related material legal proceedings to which Liggett or us is a party. A copy of Exhibit 99.1 will be furnished without charge upon written request to us at our principal executive offices, 100 S.E. Second St., 32nd Floor, Miami, Florida 33131, Attn. Investor Relations. |
Except as set forth below, there are no material changes from the risk factors set forth in Item 1A, Risk Factors, of our Annual Report on 10-K for the year ended December 31, 2009. Please refer to that section for disclosures regarding the risks and uncertainties related to our business. The risk factors in the Annual Report on Form 10-K entitled Litigation will continue to harm the tobacco industry, Individual tobacco-related cases have increased as a result of the Florida Supreme Courts ruling in Engle and Liggett may have additional payment obligations under the Master Settlement Agreement and its other settlement agreements with the states are revised to reflect the updated information concerning the number and status of cases and other matters discussed under Note 5 to our condensed consolidated financial statements and in Managements Discussion and Analysis of Financial Condition Recent Developments Tobacco Settlement Agreements, Recent Developments in Legislation, Regulation and Tobacco-Related Litigation, and Legislation and Regulation. |
- 54 -
Item 6. | Exhibits |
4.1
|
Third Supplemental Indenture, dated as of April 20, 2010, among Vector Group Ltd., the subsidiary guarantors named therein and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 in Vectors Form 8-K dated April 20, 2010). | |
4.2
|
Registration Rights Agreement, dated as of April 20, 2010, between Vector Group Ltd., the subsidiary guarantors named therein and Jefferies & Company, Inc. (incorporated by reference to Exhibit 4.1 in Vectors Form 8-K dated April 20, 2010). | |
31.1
|
Certification of Chief Executive Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2
|
Certification of Chief Financial Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1
|
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2
|
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
99.1
|
Material Legal Proceedings |
- 55 -
VECTOR GROUP LTD. (Registrant) |
||||
By: | /s/ J. Bryant Kirkland III | |||
J. Bryant Kirkland III | ||||
Vice President, Treasurer and Chief Financial Officer | ||||
- 56 -